DE280853C
(es)
|
|
|
|
|
US850370A
(en)
|
1906-06-05 |
1907-04-16 |
William L Hynes |
Water-automobile.
|
DE2156720A1
(de)
|
1971-11-16 |
1973-05-24 |
Bayer Ag |
Pyrimido eckige klammer auf 4,5-d eckige klammer zu pyrimidine
|
US3984021A
(en)
|
1972-09-11 |
1976-10-05 |
Uhlig Gerhardt E |
Safety closure container
|
US3894021A
(en)
|
1974-01-28 |
1975-07-08 |
Squibb & Sons Inc |
Derivatives of 1,7-dihydro-2H-pyrazolo{8 4{40 ,3{40 :5,6{9 pyrido{8 4,3-D{9 pyrimidine-2,4-(3H)-diones
|
JPS5120580B2
(es)
|
1974-06-19 |
1976-06-25 |
|
|
US4347348A
(en)
|
1978-06-05 |
1982-08-31 |
Chernikhov Alexei Y |
Heat-resistant heterocyclic polymers and methods for producing same
|
FR2428654A1
(fr)
|
1978-06-13 |
1980-01-11 |
Chernikhov Alexei |
Polymeres heterocycliques thermostables et leurs procedes de preparation
|
CH635828A5
(de)
|
1978-08-30 |
1983-04-29 |
Ciba Geigy Ag |
N-substituierte imide und bisimide.
|
CH641470A5
(de)
|
1978-08-30 |
1984-02-29 |
Ciba Geigy Ag |
Imidgruppen enthaltende silane.
|
US4339267A
(en)
|
1980-01-18 |
1982-07-13 |
E. I. Du Pont De Nemours And Company |
Herbicidal sulfonamides
|
US4405519A
(en)
|
1980-10-22 |
1983-09-20 |
Plastics Engineering Company |
Di-Acetylene-terminated polyimide derivatives
|
US4405520A
(en)
|
1980-10-22 |
1983-09-20 |
Plastics Engineering Company |
Addition products of di-acetylene-terminated polymide derivatives and dienophiles having terminal maleimide grops
|
US4405786A
(en)
|
1980-10-22 |
1983-09-20 |
Plastics Engineering Company |
Addition products of di-acetylene-terminated polyimide derivatives and an dienophile having ethylene groups
|
US4402878A
(en)
|
1980-10-22 |
1983-09-06 |
Plastics Engineering Company |
Addition products of di-acetylene-terminated polyimide derivatives with a polyimide having terminal non-conjugated acetylene groups
|
US4460773A
(en)
|
1982-02-05 |
1984-07-17 |
Lion Corporation |
1-Phenyl-1H-pyrazolo [3,4-b]pyrazine derivatives and process for preparing same
|
DE3432983A1
(de)
|
1983-09-07 |
1985-04-18 |
Lion Corp., Tokio/Tokyo |
1,5-disubstituierte 1h-pyrazolo(3,4-b)-pyrazin-derivate und antitumormittel, die diese enthalten
|
JPS62273979A
(ja)
|
1986-05-21 |
1987-11-28 |
Lion Corp |
1,5−置換−1H−ピラゾロ〔3,4−b〕ピラジン誘導体及び該化合物を含有する抗腫瘍剤
|
JPS6310630A
(ja)
|
1986-06-23 |
1988-01-18 |
Teijin Ltd |
芳香族ポリアミドイミドエ−テルの製造法
|
JPS6317882A
(ja)
|
1986-07-09 |
1988-01-25 |
Lion Corp |
5−置換−1H−ピラゾロ〔3,4−b〕ピラジン誘導体及び該化合物を含有する抗腫瘍剤
|
US4859672A
(en)
|
1986-10-29 |
1989-08-22 |
Rorer Pharmaceutical Corporation |
Pyrido[2,3-d]pyrimidinone and imidazo[4,5-b]pyrimidinone
|
US4874803A
(en)
|
1987-09-21 |
1989-10-17 |
Pennwalt Corporation |
Dianhydride coupled polymer stabilizers
|
DE3814549A1
(de)
|
1987-10-30 |
1989-05-18 |
Bayer Ag |
N-substituierte derivate von 1-desoxynojirimycin und 1-desoxymannonojirimycin, verfahren zu deren herstellung und deren verwendung in arzneimitteln
|
JPH029895A
(ja)
|
1988-06-28 |
1990-01-12 |
Lion Corp |
ヌクレオシド類似化合物及び抗腫瘍剤
|
DD280853A1
(de)
|
1989-03-21 |
1990-07-18 |
Akad Nauk Sssr |
Bindemittel fuer elektroden, vorzugsweise fuer polymerelektroden
|
US5159054A
(en)
|
1989-05-16 |
1992-10-27 |
The United States Of America As Represented By The Secretary Of The Navy |
Synthesis of phthalonitrile resins containing ether and imide linkages
|
JP2845957B2
(ja)
|
1989-07-17 |
1999-01-13 |
三井化学株式会社 |
イミド環を有する新規ジフェノール類およびその製造方法
|
US5726302A
(en)
|
1989-09-15 |
1998-03-10 |
Gensia Inc. |
Water soluble adenosine kinase inhibitors
|
DE3937633A1
(de)
|
1989-11-11 |
1991-05-16 |
Bayer Ag |
Heterocyclische verbindungen und deren verwendung als pigmente und farbstoffe
|
CA2072560A1
(en)
|
1989-12-28 |
1991-06-29 |
Hans-Tobias Macholdt |
Biscationic acid amide and acid imide derivatives as charge controllers
|
US5329046A
(en)
|
1989-12-28 |
1994-07-12 |
Hoechst Aktiengesellschaft |
Biscationic acid amide and imide derivatives and processes for their preparation
|
JP2883670B2
(ja)
|
1990-03-23 |
1999-04-19 |
三井化学株式会社 |
イミド環を有する新規ビスフェノール類およびその製造方法
|
GB9113137D0
(en)
|
1990-07-13 |
1991-08-07 |
Ici Plc |
Thioxo heterocycles
|
DE69130769T2
(de)
|
1990-10-03 |
1999-09-02 |
Commonwealth Scientific And Industrial Research Or |
Epoxydharze auf basis von diaminobisimidverbindungen
|
JPH04158084A
(ja)
|
1990-10-22 |
1992-06-01 |
Fuji Photo Film Co Ltd |
記録材料
|
JPH04179576A
(ja)
|
1990-11-14 |
1992-06-26 |
Fuji Photo Film Co Ltd |
記録材料
|
JPH04328121A
(ja)
|
1991-04-26 |
1992-11-17 |
Sumitomo Bakelite Co Ltd |
半導体封止用エポキシ樹脂組成物
|
AU657986B2
(en)
|
1991-06-14 |
1995-03-30 |
Pharmacia & Upjohn Company |
Imidazo(1,5-a)quinoxalines
|
DE4119767A1
(de)
|
1991-06-15 |
1992-12-17 |
Dresden Arzneimittel |
Verfahren zur herstellung von (pyrimid-2-yl-thio- bzw. seleno)-essigsaeurederivaten
|
US5521184A
(en)
|
1992-04-03 |
1996-05-28 |
Ciba-Geigy Corporation |
Pyrimidine derivatives and processes for the preparation thereof
|
JP3279635B2
(ja)
|
1992-05-18 |
2002-04-30 |
鐘淵化学工業株式会社 |
ヒドロシリル基含有イミド化合物
|
JP3232123B2
(ja)
|
1992-05-20 |
2001-11-26 |
鐘淵化学工業株式会社 |
硬化性組成物
|
EP0642510A4
(en)
|
1992-05-28 |
1997-04-02 |
Commw Scient Ind Res Org |
BISMALEIMIDE COMPOUNDS.
|
EP0672044A4
(en)
|
1992-12-07 |
1997-08-20 |
Commw Scient Ind Res Org |
BISNADIMIDE.
|
WO1994015995A1
(en)
|
1993-01-11 |
1994-07-21 |
The Trustees Of The University Of Pennsylvania |
Polycyclic aromatic compounds having nonlinear optical properties
|
AU4293193A
(en)
|
1993-04-28 |
1994-11-21 |
Du Pont Merck Pharmaceutical Company, The |
Novel trisubstituted aromatic amines useful for the treatment of cognitive deficits
|
US5536725A
(en)
|
1993-08-25 |
1996-07-16 |
Fmc Corporation |
Insecticidal substituted-2,4-diamino-5,6,7,8-tetrahydroquinazolines
|
NZ536355A
(en)
|
1993-11-30 |
2006-08-31 |
Searle & Co |
Method of treating inflammation using substituted pyrazolyl benzenesulfonamides
|
US5480887A
(en)
|
1994-02-02 |
1996-01-02 |
Eli Lilly And Company |
Protease inhibitors
|
EP0746320B1
(en)
|
1994-02-02 |
2001-01-31 |
Eli Lilly And Company |
Hiv protease inhibitors and intermediates
|
CN1085666C
(zh)
|
1994-11-14 |
2002-05-29 |
沃尼尔·朗伯公司 |
用于抑制蛋白质酪氨酸激酶介导的细胞增殖的6-芳基吡啶并[2,3-d]嘧啶和1,5-二氮杂萘
|
US7125880B1
(en)
|
1995-06-06 |
2006-10-24 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
US5783577A
(en)
|
1995-09-15 |
1998-07-21 |
Trega Biosciences, Inc. |
Synthesis of quinazolinone libraries and derivatives thereof
|
JPH09188812A
(ja)
|
1996-01-11 |
1997-07-22 |
Mitsui Toatsu Chem Inc |
結晶化促進剤
|
AU2980797A
(en)
|
1996-06-11 |
1998-01-07 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Fused heterocyclic compounds and medicinal uses thereof
|
ES2191183T3
(es)
|
1996-08-06 |
2003-09-01 |
Pfizer |
Derivados 6,6- o 6,7-biciclicos que contienen pirido o pirimido sustituidos.
|
US6184235B1
(en)
|
1996-08-14 |
2001-02-06 |
Warner-Lambert Company |
2-phenyl benzimidazole derivatives as MCP-1 antagonists
|
JP3669783B2
(ja)
|
1996-08-21 |
2005-07-13 |
三井化学株式会社 |
有機電界発光素子
|
US5994364A
(en)
|
1996-09-13 |
1999-11-30 |
Schering Corporation |
Tricyclic antitumor farnesyl protein transferase inhibitors
|
WO1998018781A2
(en)
|
1996-10-28 |
1998-05-07 |
Versicor, Inc. |
Fused 2,4-pyrimidinedione combinatorial libraries, their preparation and the use of fused 2,4-pyrimidinediones derivatives as antimicrobial agents
|
WO1998028281A1
(en)
|
1996-12-23 |
1998-07-02 |
Celltech Therapeutics Limited |
Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
|
ATE391719T1
(de)
|
1997-02-05 |
2008-04-15 |
Warner Lambert Co |
Pyrido (2,3-d) pyrimidine und 4-amino-primidine als inhibitoren der zellulären proliferation
|
CA2285263C
(en)
|
1997-04-11 |
2009-03-10 |
Abbott Laboratories |
Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission
|
ATE493389T1
(de)
|
1997-05-28 |
2011-01-15 |
Aventis Pharma Inc |
Chinoxalin-derivate die den von blutplättchen abstammenden wachstumsfaktor und/oder p56lck- tyrosinkinase hemmen
|
GB9716231D0
(en)
|
1997-07-31 |
1997-10-08 |
Amersham Int Ltd |
Base analogues
|
NZ502877A
(en)
|
1997-08-11 |
2001-11-30 |
Cor Therapeutics Inc |
Bicyclic aryl azepinone selective factor Xa inhibitors for treating thrombosis related diseases
|
KR20010023089A
(ko)
|
1997-08-20 |
2001-03-26 |
로즈 암스트롱, 크리스틴 에이. 트러트웨인 |
단백질 티로신 키나제 및 세포주기 키나제 매개의 세포증식 억제용 나프티리디논
|
US6465484B1
(en)
|
1997-09-26 |
2002-10-15 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
JPH11171865A
(ja)
|
1997-12-04 |
1999-06-29 |
Yoshitomi Pharmaceut Ind Ltd |
縮合ヘテロ環化合物
|
CA2316944A1
(en)
|
1998-02-20 |
1999-08-26 |
Mitsuru Shiraishi |
Aminoguanidinehydrazone derivative, production and use thereof
|
AU9298798A
(en)
|
1998-05-15 |
1999-12-06 |
Guilford Pharmaceuticals Inc. |
Fused tricyclic compounds which inhibit parp activity
|
US20040044012A1
(en)
|
1998-05-26 |
2004-03-04 |
Dobrusin Ellen Myra |
Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
|
EA003640B1
(ru)
|
1998-05-26 |
2003-08-28 |
Варнер-Ламберт Компани |
Бициклические пиримидины и бициклические 3,4-дигидропиримидины как ингибиторы клеточной пролиферации
|
AU4429799A
(en)
|
1998-06-12 |
1999-12-30 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
CA2339961C
(en)
|
1998-08-11 |
2009-01-20 |
Novartis Ag |
Isoquinoline derivatives with angiogenesis inhibiting activity
|
JP2000123973A
(ja)
|
1998-10-09 |
2000-04-28 |
Canon Inc |
有機発光素子
|
GB9823103D0
(en)
|
1998-10-23 |
1998-12-16 |
Pfizer Ltd |
Pharmaceutically active compounds
|
BR9914677A
(pt)
|
1998-10-23 |
2001-07-17 |
Hoffmann La Roche |
Heterociclos de nitrogênio bicìclicos
|
US6133031A
(en)
|
1999-08-19 |
2000-10-17 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of focal adhesion kinase expression
|
GB9905075D0
(en)
|
1999-03-06 |
1999-04-28 |
Zeneca Ltd |
Chemical compounds
|
DE19912638A1
(de)
|
1999-03-20 |
2000-09-21 |
Bayer Ag |
Naphthylcarbonsäureamid-substituierte Sulfonamide
|
DE19920790A1
(de)
|
1999-05-06 |
2000-11-09 |
Bayer Ag |
Bis-Sulfonamide mit anti-HCMV-Wirkung
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
JP4041624B2
(ja)
|
1999-07-21 |
2008-01-30 |
三井化学株式会社 |
有機電界発光素子
|
NZ517025A
(en)
|
1999-09-24 |
2003-07-25 |
Janssen Pharmaceutica Nv |
Antiviral compositions
|
DE19946289A1
(de)
|
1999-09-28 |
2001-03-29 |
Basf Ag |
Benzodiazepin-Derivate, deren Herstellung und Anwendung
|
MXPA02003841A
(es)
|
1999-10-21 |
2002-09-30 |
Hoffmann La Roche |
Heterociclos de nitrogeno biciclicos alquilamino substituidos como inhibidores de proteina p38.
|
IL149100A0
(en)
|
1999-10-21 |
2002-11-10 |
Hoffmann La Roche |
Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
|
TWI271406B
(en)
|
1999-12-13 |
2007-01-21 |
Eisai Co Ltd |
Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
|
EP1242382B1
(en)
|
1999-12-29 |
2007-02-07 |
Wyeth |
Tricyclic protein kinase inhibitors
|
US7094780B1
(en)
|
2000-01-24 |
2006-08-22 |
Warner Lambert Company Llc |
3-aminoquinazolin-2,4-dione antibacterial agents
|
KR20020070520A
(ko)
|
2000-01-27 |
2002-09-09 |
워너-램버트 캄파니 |
신경퇴행성 질병의 치료를 위한 피리도피리미디논 유도체
|
AU2001240542A1
(en)
|
2000-02-01 |
2001-08-14 |
Basf Aktiengesellschaft |
Heterocyclic compounds and their use as parp inhibitors
|
CA2400479C
(en)
|
2000-02-04 |
2010-10-05 |
Millennium Pharmaceuticals, Inc. |
Platelet adp receptor inhibitors
|
AU2001231710A1
(en)
|
2000-02-09 |
2001-08-20 |
Novartis Ag |
Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
AU2001235804A1
(en)
|
2000-03-06 |
2001-09-17 |
Astrazeneca Ab |
Therapy
|
DE10012549A1
(de)
|
2000-03-15 |
2001-09-20 |
Bayer Ag |
Arzneimittel gegen virale Erkrankungen
|
JP2001265031A
(ja)
|
2000-03-15 |
2001-09-28 |
Fuji Xerox Co Ltd |
電子写真感光体、プロセスカートリッジ、及び、電子写真装置
|
CN101016296A
(zh)
|
2000-04-28 |
2007-08-15 |
阿卡蒂亚药品公司 |
毒蕈碱性激动剂
|
AU2001264566A1
(en)
|
2000-05-05 |
2001-11-20 |
Cor Therapeutics, Inc. |
Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
|
NZ523184A
(en)
|
2000-06-23 |
2004-06-25 |
Bristol Myers Squibb Pharma Co |
1 - (heteroaryl-phenyl) - condensed pyrazol derivatives as factor Xa inhibitors
|
CA2413330A1
(en)
|
2000-06-28 |
2002-01-03 |
Smithkline Beecham P.L.C. |
Wet milling process
|
US20050009876A1
(en)
|
2000-07-31 |
2005-01-13 |
Bhagwat Shripad S. |
Indazole compounds, compositions thereof and methods of treatment therewith
|
EP1325006A2
(en)
|
2000-08-07 |
2003-07-09 |
Neurogen Corporation |
Heterocyclic compounds as ligands of the gaba a? receptor
|
AU2001286454B2
(en)
|
2000-08-14 |
2006-09-14 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted pyrazoles
|
PL365606A1
(en)
|
2000-09-06 |
2005-01-10 |
Ortho Mcneil Pharmaceutical, Inc. |
A method for treating allergies using substituted pyrazoles
|
GB0025782D0
(en)
|
2000-10-20 |
2000-12-06 |
Pfizer Ltd |
Use of inhibitors
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
GB0100621D0
(en)
|
2001-01-10 |
2001-02-21 |
Vernalis Res Ltd |
Chemical compounds VI
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
AP1699A
(en)
|
2001-03-21 |
2006-12-26 |
Warner Lambert Co |
New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
|
US6998408B2
(en)
|
2001-03-23 |
2006-02-14 |
Bristol-Myers Squibb Pharma Company |
6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors
|
JP2002296731A
(ja)
|
2001-03-30 |
2002-10-09 |
Fuji Photo Film Co Ltd |
熱現像カラー画像記録材料
|
ATE449763T1
(de)
|
2001-04-16 |
2009-12-15 |
Eisai R&D Man Co Ltd |
1h-indazolverbindungen die jnk hemmen
|
US7074801B1
(en)
|
2001-04-26 |
2006-07-11 |
Eisai Co., Ltd. |
Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof
|
CA2446514A1
(en)
|
2001-04-30 |
2002-11-07 |
Glaxo Group Limited |
Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
|
WO2002094825A1
(fr)
|
2001-05-22 |
2002-11-28 |
Banyu Pharmaceutical Co., Ltd. |
Nouveau derive de spiropiperidine
|
US20030114448A1
(en)
|
2001-05-31 |
2003-06-19 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
BR0210028A
(pt)
|
2001-06-19 |
2004-06-22 |
Warner Lambert Co |
Agentes antibacterianos
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
AU2002315389A1
(en)
|
2001-06-21 |
2003-01-08 |
Ariad Pharmaceuticals, Inc. |
Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
|
WO2003000690A1
(en)
|
2001-06-25 |
2003-01-03 |
Aventis Pharmaceuticals Inc. |
Synthesis of heterocyclic compounds employing microwave technology
|
US20040235867A1
(en)
|
2001-07-24 |
2004-11-25 |
Bilodeau Mark T. |
Tyrosine kinase inhibitors
|
HUP0401108A2
(hu)
|
2001-08-07 |
2004-09-28 |
Banyu Pharmaceutical Co., Ltd. |
Spirovegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
|
EP1436291B1
(en)
|
2001-09-19 |
2009-01-14 |
Aventis Pharma S.A. |
Indolizines as kinase protein inhibitors
|
ATE335490T1
(de)
|
2001-10-30 |
2006-09-15 |
Novartis Pharma Gmbh |
Staurosporin-derivate als hemmer der flt3- rezeptor-tyrosinkinase-wirkung
|
PL369259A1
(en)
|
2001-11-01 |
2005-04-18 |
Janssen Pharmaceutica N.V. |
Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
|
KR20050042062A
(ko)
|
2001-11-07 |
2005-05-04 |
에프. 호프만-라 로슈 아게 |
아미노피리미딘 및 피리딘
|
EP1456652A4
(en)
|
2001-11-13 |
2005-11-02 |
Dana Farber Cancer Inst Inc |
IMMUNOCELL ACTIVATION MODULATING SUBSTANCES AND USE METHOD THEREFOR
|
GB0129476D0
(en)
|
2001-12-10 |
2002-01-30 |
Syngenta Participations Ag |
Organic compounds
|
CN101906104B
(zh)
|
2002-01-22 |
2013-06-05 |
沃尼尔·朗伯有限责任公司 |
2-(吡啶-2-基氨基)-吡啶并[2,3-d]嘧啶-7-酮
|
IL163748A0
(en)
|
2002-03-05 |
2005-12-18 |
Merck Frosst Canada Inc |
Cathepsin cysteine protease inhibitors
|
US6815519B2
(en)
|
2002-03-22 |
2004-11-09 |
Chung-Shan Institute Of Science & Technology |
Acidic fluorine-containing poly (siloxane amideimide) silica hybrids
|
JP2006503802A
(ja)
|
2002-04-03 |
2006-02-02 |
エフ.ホフマン−ラ ロシュ アーゲー |
イミダゾ縮合化合物
|
EP1506175B1
(en)
|
2002-05-15 |
2009-04-01 |
Janssen Pharmaceutica N.V. |
N-substituted tricyclic 3-aminopyrazoles as pdgf receptor inhibitors
|
JP4499342B2
(ja)
|
2002-05-16 |
2010-07-07 |
株式会社カネカ |
SiH基を含有する含窒素有機系化合物の製造方法
|
ATE478867T1
(de)
|
2002-05-23 |
2010-09-15 |
Novartis Vaccines & Diagnostic |
Substituierte quinazolinone verbindungen
|
PE20040522A1
(es)
|
2002-05-29 |
2004-09-28 |
Novartis Ag |
Derivados de diarilurea dependientes de la cinasa de proteina
|
US7119111B2
(en)
|
2002-05-29 |
2006-10-10 |
Amgen, Inc. |
2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
GB0215676D0
(en)
|
2002-07-05 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
PA8577501A1
(es)
|
2002-07-25 |
2004-02-07 |
Warner Lambert Co |
Inhibidores de quinasas
|
ES2337782T3
(es)
|
2002-07-29 |
2010-04-29 |
Rigel Pharmaceuticals, Inc. |
Metodos para tratar o prevenir enfermedades autoinmunitarias con compuestos de 2,4-pirimidindiamina.
|
MXPA05001332A
(es)
|
2002-08-06 |
2005-04-28 |
Hoffmann La Roche |
6-alcoxi-pirido-pirimidinas como inhibidores de cinasa del map p-38.
|
EP1388541A1
(en)
|
2002-08-09 |
2004-02-11 |
Centre National De La Recherche Scientifique (Cnrs) |
Pyrrolopyrazines as kinase inhibitors
|
US7084270B2
(en)
|
2002-08-14 |
2006-08-01 |
Hoffman-La Roche Inc. |
Pyrimido compounds having antiproliferative activity
|
GB0220187D0
(en)
|
2002-08-30 |
2002-10-09 |
Novartis Ag |
Organic compounds
|
GB0223349D0
(en)
|
2002-10-08 |
2002-11-13 |
Merck Sharp & Dohme |
Therapeutic agents
|
TW200413381A
(en)
|
2002-11-04 |
2004-08-01 |
Hoffmann La Roche |
Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
|
US7112676B2
(en)
|
2002-11-04 |
2006-09-26 |
Hoffmann-La Roche Inc. |
Pyrimido compounds having antiproliferative activity
|
US7384937B2
(en)
|
2002-11-06 |
2008-06-10 |
Bristol-Myers Squibb Co. |
Fused heterocyclic compounds and use thereof
|
TWI335913B
(en)
|
2002-11-15 |
2011-01-11 |
Vertex Pharma |
Diaminotriazoles useful as inhibitors of protein kinases
|
BR0316375A
(pt)
|
2002-11-18 |
2005-10-04 |
Hoffmann La Roche |
Diazinopirimidinas
|
CA2502970A1
(en)
|
2002-11-28 |
2004-06-10 |
Schering Aktiengesellschaft |
Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
|
US7244748B2
(en)
|
2002-12-06 |
2007-07-17 |
Purdue Research Foundation |
Pyridines for treating injured mammalian nerve tissue
|
EP1571146A4
(en)
|
2002-12-10 |
2010-09-01 |
Ono Pharmaceutical Co |
NITROGENIC HETEROCYCLIC COMPOUNDS AND THEIR MEDICAL USE
|
UA80171C2
(en)
|
2002-12-19 |
2007-08-27 |
Pfizer Prod Inc |
Pyrrolopyrimidine derivatives
|
UA80767C2
(en)
|
2002-12-20 |
2007-10-25 |
Pfizer Prod Inc |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
US7098332B2
(en)
|
2002-12-20 |
2006-08-29 |
Hoffmann-La Roche Inc. |
5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones
|
BR0316880A
(pt)
|
2002-12-23 |
2005-10-25 |
Wyeth Corp |
Anticorpos contra pd-1 e usos dos mesmos
|
JP2004203749A
(ja)
|
2002-12-24 |
2004-07-22 |
Kanegafuchi Chem Ind Co Ltd |
SiH基を含有する含窒素有機系化合物の製造方法
|
EP1590341B1
(en)
|
2003-01-17 |
2009-06-17 |
Warner-Lambert Company LLC |
2-aminopyridine substituted heterocycles as inhibitors of cellular proliferation
|
GB0305929D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
US7135469B2
(en)
|
2003-03-18 |
2006-11-14 |
Bristol Myers Squibb, Co. |
Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
|
CN1894234A
(zh)
|
2003-03-25 |
2007-01-10 |
武田药品工业株式会社 |
二肽基肽酶抑制剂
|
GB0308208D0
(en)
|
2003-04-09 |
2003-05-14 |
Glaxo Group Ltd |
Chemical compounds
|
MXPA05010765A
(es)
|
2003-04-10 |
2005-12-12 |
Hoffmann La Roche |
Compuestos pirimido.
|
CA2523261C
(en)
|
2003-05-05 |
2009-07-07 |
F. Hoffmann-La Roche Ag |
Fused pyrimidine derivatives with crf activity
|
JP2004346145A
(ja)
|
2003-05-21 |
2004-12-09 |
Teijin Ltd |
イミド組成物およびそれからなる樹脂組成物、及びその製造方法
|
US7625909B2
(en)
|
2003-05-23 |
2009-12-01 |
Novartis Vaccines And Diagnostics, Inc. |
Substituted quinazolinone compounds
|
ES2341545T3
(es)
|
2003-06-06 |
2010-06-22 |
Arexis Ab |
Uso de compuestos heterociclicos condensados como inhibidores de scce para el tratamiento de enfermedades de la piel.
|
IL156495A0
(en)
|
2003-06-17 |
2004-01-04 |
Prochon Biotech Ltd |
Use of fgfr3 antagonists for treating t cell mediated diseases
|
WO2004113307A1
(ja)
|
2003-06-18 |
2004-12-29 |
Ube Industries, Ltd. |
ピリミジン−4−オン化合物の製造方法
|
JP2005015395A
(ja)
|
2003-06-26 |
2005-01-20 |
Japan Science & Technology Agency |
新規ピリミドピリミジンヌクレオシドとその構造類縁体
|
JP5129957B2
(ja)
|
2003-07-03 |
2013-01-30 |
ミリアド ジェネティクス, インコーポレイテッド |
カスパーゼの活性化因子およびアポトーシスの誘発因子としての4−アリールアミノ−キナゾリン
|
AR045037A1
(es)
|
2003-07-10 |
2005-10-12 |
Aventis Pharma Sa |
Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion.
|
AU2004260689B8
(en)
|
2003-07-29 |
2008-05-15 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
US7390820B2
(en)
|
2003-08-25 |
2008-06-24 |
Amgen Inc. |
Substituted quinolinone derivatives and methods of use
|
US20050070542A1
(en)
|
2003-09-03 |
2005-03-31 |
Hodgetts Kevin J. |
5-Aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds
|
CN101906106A
(zh)
|
2003-09-18 |
2010-12-08 |
康福玛医药公司 |
作为hsp90-抑制剂的新的杂环化合物
|
CA2537325A1
(en)
|
2003-09-19 |
2005-03-31 |
Gilead Sciences, Inc. |
Aza-quinolinol phosphonate integrase inhibitor compounds
|
PE20050952A1
(es)
|
2003-09-24 |
2005-12-19 |
Novartis Ag |
Derivados de isoquinolina como inhibidores de b-raf
|
JP4833069B2
(ja)
|
2003-10-01 |
2011-12-07 |
ゼンション・リミテッド |
テトラヒドロ−ナフタレンおよび尿素誘導体
|
EP1673343A4
(en)
*
|
2003-10-08 |
2008-09-10 |
Irm Llc |
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
US20090099165A1
(en)
|
2003-10-14 |
2009-04-16 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Protein Kinase Inhibitors
|
BRPI0416656A
(pt)
|
2003-11-17 |
2007-01-16 |
Pfizer Prod Inc |
compostos de pirrolopirimidina úteis no tratamento do cáncer
|
WO2005056524A2
(en)
|
2003-12-09 |
2005-06-23 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
WO2005066162A1
(en)
|
2003-12-23 |
2005-07-21 |
Human Biomolecular Research Institute |
Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer
|
KR100703068B1
(ko)
|
2003-12-30 |
2007-04-05 |
에스케이케미칼주식회사 |
피리딘 유도체와 이의 제조방법, 및 이를 포함하는약제조성물
|
US20050222171A1
(en)
|
2004-01-22 |
2005-10-06 |
Guido Bold |
Organic compounds
|
AU2005206562A1
(en)
|
2004-01-23 |
2005-08-04 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
ME01065B
(me)
|
2004-01-23 |
2012-10-20 |
Janssen Pharmaceutica Nv |
Derivati kvinolina i njihova upotreba kao mikobakterijskih inhibitora
|
US20060019952A1
(en)
|
2004-01-29 |
2006-01-26 |
Elixir Pharmaceuticals, Inc. |
Anti-viral therapeutics
|
GB0402137D0
(en)
|
2004-01-30 |
2004-03-03 |
Smithkline Beecham Corp |
Novel compounds
|
BRPI0507668A
(pt)
|
2004-02-14 |
2007-07-17 |
Irm Llc |
compostos e composições como inibidores de proteìna cinase
|
WO2005082903A1
(en)
|
2004-02-18 |
2005-09-09 |
Warner-Lambert Company Llc |
2-(pyridin-3-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
|
JP2007523938A
(ja)
|
2004-02-27 |
2007-08-23 |
エフ.ホフマン−ラ ロシュ アーゲー |
ピラゾールの縮合誘導体
|
CA2558109A1
(en)
|
2004-02-27 |
2005-09-15 |
F. Hoffmann-La Roche Ag |
Heteroaryl-fused pyrazolo derivatives
|
US20080004263A1
(en)
|
2004-03-04 |
2008-01-03 |
Santora Vincent J |
Ligands of Follicle Stimulating Hormone Receptor and Methods of Use Thereof
|
EP1724264A1
(en)
|
2004-03-10 |
2006-11-22 |
Ono Pharmaceutical Co., Ltd. |
Nitriles and medicinal compositions containing the same as the active ingredient
|
WO2005092901A1
(ja)
|
2004-03-29 |
2005-10-06 |
Mitsui Chemicals, Inc. |
新規化合物、および該化合物を用いた有機エレクトロニクス素子
|
WO2005105097A2
(en)
*
|
2004-04-28 |
2005-11-10 |
Gpc Biotech Ag |
Pyridopyrimidines for treating inflammatory and other diseases
|
JP2005320288A
(ja)
|
2004-05-10 |
2005-11-17 |
Mitsui Chemicals Inc |
テトラカルボン酸誘導体、および該化合物を用いた電子写真感光体、電子写真装置
|
US20050256309A1
(en)
|
2004-05-12 |
2005-11-17 |
Altenbach Robert J |
Tri-and bi-cyclic heteroaryl histamine-3 receptor ligands
|
MXPA06013805A
(es)
|
2004-05-27 |
2007-02-02 |
Pfizer Prod Inc |
Derivados de pirrolopirimidina de utilidad en el tratamiento contra el cancer.
|
EP1761539A1
(en)
|
2004-06-02 |
2007-03-14 |
Takeda Pharmaceutical Company Limited |
Indole derivative and use for treatment of cancer
|
PE20060426A1
(es)
|
2004-06-02 |
2006-06-28 |
Schering Corp |
DERIVADOS DE ACIDO TARTARICO COMO INHIBIDORES DE MMPs, ADAMs, TACE Y TNF-alfa
|
AR049511A1
(es)
|
2004-06-10 |
2006-08-09 |
Irm Llc |
Compuestos y composiciones como inhibidores de quinasa de proteina
|
BRPI0511967B8
(pt)
|
2004-06-11 |
2021-05-25 |
Japan Tobacco Inc |
derivados de 5-amino-2,4,7-trioxo-3,4,7,8-tetrahidro-2h-pirido[2,3-d] pirimidina, seu uso e composição farmacêutica que os compreende
|
GB0512324D0
(en)
|
2005-06-16 |
2005-07-27 |
Novartis Ag |
Organic compounds
|
JP2006028027A
(ja)
|
2004-07-12 |
2006-02-02 |
Mitsui Chemicals Inc |
テトラカルボン酸誘導体、および該化合物を用いた電子写真感光体、電子写真装置
|
CA2576924A1
(en)
|
2004-08-31 |
2006-03-09 |
F. Hoffmann-La Roche Ag |
Amide derivatives of 7-amino-3-phenyl-dihydropyrimido [4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents
|
AU2005278959A1
(en)
|
2004-08-31 |
2006-03-09 |
Astrazeneca Ab |
Quinazolinone derivatives and their use as B-Raf inhibitors
|
BRPI0514738A
(pt)
|
2004-08-31 |
2008-06-24 |
Hoffmann La Roche |
derivados de amida de 3-fenil-diidropirimido[4,5-d]pirimidinonas, sua fabricação e aplicação como agentes farmacêuticos
|
DE102004042667A1
(de)
|
2004-09-01 |
2006-03-30 |
Ewald Dörken Ag |
Mehrschichtige Gebäudewand
|
US7687113B2
(en)
|
2004-09-10 |
2010-03-30 |
Ube Industries, Inc. |
Modified polyimide resin and curable resin composition
|
CA2584412C
(en)
|
2004-09-14 |
2017-05-09 |
Minerva Biotechnologies Corporation |
Methods for diagnosis and treatment of cancer
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
WO2006038112A1
(en)
|
2004-10-01 |
2006-04-13 |
Warner-Lambert Company Llc |
Use of kinase inhibitors to promote neochondrogenesis
|
FR2876582B1
(fr)
|
2004-10-15 |
2007-01-05 |
Centre Nat Rech Scient Cnrse |
Utilisation de derives de pyrrolo-pyrazines pour la fabrication de medicaments pour le traitement de la mucoviscidose et de maladies liees a un defaut d'adressage des proteines dans les cellules
|
US20060135553A1
(en)
|
2004-10-28 |
2006-06-22 |
Campbell David A |
Imidazole derivatives
|
WO2006050076A1
(en)
|
2004-10-29 |
2006-05-11 |
Janssen Pharmaceutica, N.V. |
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
|
JP2008519036A
(ja)
|
2004-11-08 |
2008-06-05 |
バクスター・インターナショナル・インコーポレイテッド |
チューブリン阻害化合物のナノ粒子組成物
|
CA2587153A1
(en)
|
2004-11-18 |
2006-05-26 |
Incyte Corporation |
Inhibitors of 11-.beta. hydroxyl steroid dehydrogenase type 1 and methods of using the same
|
US20060122185A1
(en)
|
2004-11-22 |
2006-06-08 |
Jeremy Green |
Bicyclic inhibitors of Rho kinase
|
AU2005309019A1
(en)
|
2004-11-24 |
2006-06-01 |
Novartis Ag |
Combinations of JAK inhibitors and at least one of Bcr-Abl, Flt-3, FAK or RAF kinase inhibitors
|
MY140748A
(en)
|
2004-12-06 |
2010-01-15 |
Astrazeneca Ab |
Novel pyrrolo [3,2-d] pyrimidin-4-one derivatives and their use in therapy
|
US7767687B2
(en)
|
2004-12-13 |
2010-08-03 |
Biogen Idec Ma Inc. |
Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitors
|
US20100152206A1
(en)
|
2005-01-07 |
2010-06-17 |
Ralph Mazitschek |
Bicyclic Dihydropyrimidines and Uses Thereof
|
DE102005008310A1
(de)
|
2005-02-17 |
2006-08-24 |
Schering Ag |
Verwendung von CDKII Inhibitoren zur Fertilitätskontrolle
|
BRPI0607402A2
(pt)
|
2005-03-01 |
2009-09-01 |
Pfizer Ltd |
uso de inibidores de pde7 para o tratamento de dor neuropática
|
US7297700B2
(en)
|
2005-03-24 |
2007-11-20 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
US8859495B2
(en)
|
2005-03-30 |
2014-10-14 |
Minerva Biotechnologies Corporation |
Methods for stimulating or enhancing proliferation of non-tumorous cells expressing MUC1 receptors
|
JP2006284843A
(ja)
|
2005-03-31 |
2006-10-19 |
Mitsui Chemicals Inc |
テトラカルボン酸誘導体を用いた電子写真感光体、電子写真装置
|
US20060223993A1
(en)
|
2005-04-01 |
2006-10-05 |
Connor Daniel M |
Colorant compounds, intermediates, and compositions
|
JP2006316054A
(ja)
|
2005-04-15 |
2006-11-24 |
Tanabe Seiyaku Co Ltd |
高コンダクタンス型カルシウム感受性kチャネル開口薬
|
KR100781704B1
(ko)
|
2005-04-20 |
2007-12-03 |
에스케이케미칼주식회사 |
피리딘 유도체와 이의 제조방법, 및 이를 포함하는약제조성물
|
JP5198256B2
(ja)
|
2005-05-04 |
2013-05-15 |
エボテク エージー |
縮合複素環式化合物、並びにそれらの組成物及び使用
|
EP3530736A3
(en)
|
2005-05-09 |
2019-11-06 |
ONO Pharmaceutical Co., Ltd. |
Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
|
WO2006124731A2
(en)
*
|
2005-05-12 |
2006-11-23 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
US8183248B2
(en)
|
2005-05-13 |
2012-05-22 |
Irm Llc |
Substituted pyrrolo[2,3-d]pyrimidines and compositions as protein kinase inhibitors
|
WO2006135821A2
(en)
|
2005-06-09 |
2006-12-21 |
Achille Carlisle Tisdelle |
Vehicular head and neck safety system and method
|
GB0512844D0
(en)
|
2005-06-23 |
2005-08-03 |
Novartis Ag |
Organic compounds
|
WO2007005874A2
(en)
|
2005-07-01 |
2007-01-11 |
Medarex, Inc. |
Human monoclonal antibodies to programmed death ligand 1 (pd-l1)
|
EP1915377A1
(en)
|
2005-07-22 |
2008-04-30 |
Sunesis Pharmaceuticals, Inc. |
Pyrazolo pyrimidines useful as aurora kinase inhibitors
|
US20100216798A1
(en)
|
2005-07-29 |
2010-08-26 |
Astellas Pharma Inc |
Fused heterocycles as lck inhibitors
|
ES2270715B1
(es)
|
2005-07-29 |
2008-04-01 |
Laboratorios Almirall S.A. |
Nuevos derivados de pirazina.
|
AU2006279992A1
(en)
|
2005-08-09 |
2007-02-22 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
JP5016601B2
(ja)
|
2005-08-16 |
2012-09-05 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
タンパク質キナーゼ阻害剤としての化合物および組成物
|
CN101242832B
(zh)
|
2005-08-25 |
2011-08-10 |
霍夫曼-拉罗奇有限公司 |
用作p38 MAP激酶抑制剂的稠合吡唑
|
US7678917B2
(en)
|
2005-09-01 |
2010-03-16 |
Hoffman-La Roche Inc. |
Factor Xa inhibitors
|
JP2009507022A
(ja)
|
2005-09-06 |
2009-02-19 |
スミスクライン ビーチャム コーポレーション |
ベンズイミダゾールチオフェン類の位置選択的調製方法
|
WO2007032466A1
(ja)
|
2005-09-15 |
2007-03-22 |
Aska Pharmaceutical Co., Ltd. |
複素環化合物、その製造方法並びに用途
|
US20070116984A1
(en)
|
2005-09-21 |
2007-05-24 |
Doosan Corporation |
Spiro-compound for electroluminescent display device and electroluminescent display device comprising the same
|
US7482360B2
(en)
|
2005-09-23 |
2009-01-27 |
Schering Corporation |
Fused tetracyclic mGluR1 antagonists as therapeutic agents
|
DE102005048072A1
(de)
|
2005-09-24 |
2007-04-05 |
Bayer Cropscience Ag |
Thiazole als Fungizide
|
AU2006302148B2
(en)
|
2005-10-07 |
2012-12-06 |
Exelixis, Inc. |
Pyridopyrimidinone inhibitors of PI3Kalpha
|
JP5270353B2
(ja)
|
2005-10-07 |
2013-08-21 |
エクセリクシス, インク. |
ホスファチジルイノシトール3−キナーゼインヒビターとその使用方法
|
WO2007061554A2
(en)
|
2005-10-21 |
2007-05-31 |
Purdue Research Foundation |
Dosage of 4-aminopyridine derivatives for treatment of central nervous system injuries
|
KR20080066821A
(ko)
|
2005-10-26 |
2008-07-16 |
베링거 인겔하임 인터내셔날 게엠베하 |
Mch 길항 활성을 가진 (헤테로)아릴 화합물 및 당해화합물을 포함하는 약제
|
US8067457B2
(en)
|
2005-11-01 |
2011-11-29 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as antagonists of CCR2
|
BR122021011788B1
(pt)
|
2005-11-01 |
2022-01-25 |
Impact Biomedicines, Inc |
Inibidores de biaril meta pirimidina de cinases, composição farmacêutica e processo para preparar uma composição farmacêutica
|
US8604042B2
(en)
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
JP5116687B2
(ja)
|
2005-11-02 |
2013-01-09 |
バイエル・ファルマ・アクチェンゲゼルシャフト |
がんおよび他の過剰増殖性疾患の処置のためのピロロ[2,1−f][1,2,4]トリアジン−4−イルアミンIGF−1Rキナーゼ阻害剤
|
WO2007056023A2
(en)
|
2005-11-02 |
2007-05-18 |
Targegen, Inc. |
Thiazole inhibitors targeting resistant kinase mutations
|
DE602006018057D1
(de)
|
2005-11-10 |
2010-12-16 |
Chemocentryx Inc |
Substituierte chinolone und verwendungsverfahren
|
KR101318127B1
(ko)
|
2005-11-10 |
2013-10-16 |
엠에스디 가부시키가이샤 |
아자 치환된 스피로 유도체
|
WO2007058626A1
(en)
|
2005-11-16 |
2007-05-24 |
S*Bio Pte Ltd |
Indazole compounds
|
AR057986A1
(es)
|
2005-11-21 |
2008-01-09 |
Japan Tobacco Inc |
Compuesto heterociclico y su uso farmaceutico
|
KR20130141706A
(ko)
|
2005-12-02 |
2013-12-26 |
바이엘 헬스케어 엘엘씨 |
과다-증식성 장애 및 맥관형성과 관련된 질환의 치료에 유용한 치환된 4-아미노-피롤로트리아진 유도체
|
PE20070855A1
(es)
|
2005-12-02 |
2007-10-14 |
Bayer Pharmaceuticals Corp |
Derivados de 4-amino-pirrolotriazina sustituida como inhibidores de quinasas
|
JP2009519908A
(ja)
|
2005-12-08 |
2009-05-21 |
ミレニアム・ファーマシューティカルズ・インコーポレイテッド |
キナーゼ阻害活性を有する二環式化合物
|
WO2007066189A2
(en)
|
2005-12-09 |
2007-06-14 |
Pfizer Products Inc. |
Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea
|
EP1968950A4
(en)
|
2005-12-19 |
2010-04-28 |
Genentech Inc |
PYRIMIDINKINASEINHIBITOREN
|
BRPI0620408B8
(pt)
|
2005-12-21 |
2021-05-25 |
Novartis Ag |
derivados de pirimidinil aril uréia sendo inibidores de fgf, seus usos, e preparação farmacêutica
|
WO2007084314A2
(en)
|
2006-01-12 |
2007-07-26 |
Incyte Corporation |
MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
UY30118A1
(es)
|
2006-01-31 |
2007-06-29 |
Tanabe Seiyaku Co |
Compueto amina trisustituido
|
US7427625B2
(en)
|
2006-02-08 |
2008-09-23 |
Janssen Pharmaceutica, N.V. |
Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors
|
JP2009528989A
(ja)
|
2006-02-17 |
2009-08-13 |
ファイザー・リミテッド |
Tlr7変調剤としての3−デアザプリン誘導体
|
EP2233472B1
(en)
|
2006-03-28 |
2014-01-15 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
WO2007112347A1
(en)
|
2006-03-28 |
2007-10-04 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
WO2008117269A2
(en)
|
2007-03-28 |
2008-10-02 |
Atir Holding S.A. |
Heterotri cyciii c compounds as serotonergic and/or dopaminergic agents and uses thereof
|
EA200870385A1
(ru)
|
2006-03-29 |
2009-04-28 |
Фолдркс Фармасьютикалз, Инк. |
Ингибирование токсичности альфа-синуклеина
|
ATE523487T1
(de)
|
2006-04-06 |
2011-09-15 |
Wisconsin Alumni Res Found |
2-methylen-1-alpha-dihydroxy-19,21-dinor-vitami - d3-analoga und ihre anwendung
|
EP2010534A4
(en)
|
2006-04-13 |
2010-08-18 |
Astrazeneca Ab |
THIOXANTHINE DERIVATIVES AND THEIR USE AS DFO INHIBITORS
|
GB0608386D0
(en)
|
2006-04-27 |
2006-06-07 |
Senexis Ltd |
Compounds
|
US7998978B2
(en)
|
2006-05-01 |
2011-08-16 |
Pfizer Inc. |
Substituted 2-amino-fused heterocyclic compounds
|
CN101437822B
(zh)
*
|
2006-05-11 |
2012-11-28 |
Irm责任有限公司 |
作为蛋白激酶抑制剂的化合物和组合物
|
RU2008149245A
(ru)
|
2006-05-15 |
2010-06-20 |
Айрм Ллк (Bm) |
Композиции и способы ингибирования рецепторных киназ fgf
|
WO2007143600A2
(en)
|
2006-06-05 |
2007-12-13 |
Incyte Corporation |
Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases
|
DE102006027156A1
(de)
|
2006-06-08 |
2007-12-13 |
Bayer Schering Pharma Ag |
Sulfimide als Proteinkinaseinhibitoren
|
CA2656825C
(en)
|
2006-06-22 |
2013-12-10 |
Prana Biotechnology Limited |
Method of treatment and agents useful for same
|
EP2044063A1
(en)
|
2006-06-30 |
2009-04-08 |
Astra Zeneca AB |
Pyrimidine derivatives useful in the treatment of cancer
|
WO2008005877A2
(en)
|
2006-06-30 |
2008-01-10 |
Board Of Regents, The University Of Texas System |
Inhibitors of c-kit and uses thereof
|
EP2041132A2
(en)
|
2006-07-06 |
2009-04-01 |
Boehringer Ingelheim International GmbH |
New compounds
|
US8030487B2
(en)
|
2006-07-07 |
2011-10-04 |
Targegen, Inc. |
2-amino—5-substituted pyrimidine inhibitors
|
TW200811134A
(en)
|
2006-07-12 |
2008-03-01 |
Irm Llc |
Compounds and compositions as protein kinase inhibitors
|
WO2008012635A2
(en)
|
2006-07-26 |
2008-01-31 |
Pfizer Products Inc. |
Amine derivatives useful as anticancer agents
|
JP2010500372A
(ja)
|
2006-08-09 |
2010-01-07 |
スミスクライン ビーチャム コーポレーション |
オピオイド受容体に対するアンタゴニストまたはインバースアゴニストとしての新規化合物
|
JP2010500994A
(ja)
|
2006-08-16 |
2010-01-14 |
エグゼリクシス, インコーポレイテッド |
Pi3kおよびmekモジュレーターを使用する方法
|
DE102006041382A1
(de)
|
2006-08-29 |
2008-03-20 |
Bayer Schering Pharma Ag |
Carbamoyl-Sulfoximide als Proteinkinaseinhibitoren
|
PT2061765E
(pt)
|
2006-09-01 |
2015-02-06 |
Senhwa Biosciences Inc |
Moduladores de serina-treonina-proteína-quinase e de parp
|
CA2662677C
(en)
|
2006-09-05 |
2016-05-31 |
Emory University |
Kinase inhibitors for preventing or treating pathogen infection and method of use thereof
|
JP2010502751A
(ja)
|
2006-09-11 |
2010-01-28 |
シージーアイ ファーマシューティカルズ,インコーポレイティド |
キナーゼ阻害物質、およびキナーゼ阻害物質の使用および同定方法
|
US7897762B2
(en)
|
2006-09-14 |
2011-03-01 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of proliferative diseases
|
JP5372759B2
(ja)
|
2006-09-21 |
2013-12-18 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
グルコピラノシル−置換ジフルオロベンジル−ベンゼン誘導体、該化合物を含有する医薬品及びその使用と調製方法
|
DE602007011645D1
(de)
|
2006-09-22 |
2011-02-10 |
Glaxo Group Ltd |
Pyrroloä2, 3-büpyridin-4-yl-benzolsulfonamidverbindungen als ikk2-hemmer
|
US20100029636A1
(en)
|
2006-09-28 |
2010-02-04 |
Peter Buehlmayer |
Lck inhibitors
|
KR101101675B1
(ko)
|
2006-10-02 |
2011-12-30 |
노파르티스 아게 |
단백질 키나제 억제제로서의 화합물 및 조성물
|
JP2010508322A
(ja)
|
2006-10-30 |
2010-03-18 |
グラクソ グループ リミテッド |
システインプロテアーゼ阻害薬としての新規置換ピリジン誘導体
|
US7858645B2
(en)
|
2006-11-01 |
2010-12-28 |
Hoffmann-La Roche Inc. |
Indazole derivatives
|
JP5244118B2
(ja)
|
2006-11-10 |
2013-07-24 |
ブリストル−マイヤーズ スクイブ カンパニー |
新規キナーゼ阻害剤
|
US7892454B2
(en)
|
2006-11-17 |
2011-02-22 |
Polyera Corporation |
Acene-based organic semiconductor materials and methods of preparing and using the same
|
EP2086974B1
(en)
|
2006-11-17 |
2013-07-24 |
Polyera Corporation |
Diimide-based semiconductor materials and methods of preparing and using the same
|
KR20080045536A
(ko)
|
2006-11-20 |
2008-05-23 |
에스케이케미칼주식회사 |
피리딘 화합물을 포함하는 간염 치료 및 예방 또는 간 보호효능을 갖는 약제 조성물
|
EA026126B1
(ru)
|
2006-11-22 |
2017-03-31 |
Инсайт Холдингс Корпорейшн |
Имидазотриазины и имидазопиримидины в качестве ингибиторов киназы
|
WO2008076278A2
(en)
|
2006-12-13 |
2008-06-26 |
Schering Corporation |
Methods of cancer treatment with igf1r inhibitors
|
WO2008071455A1
(en)
|
2006-12-15 |
2008-06-19 |
Bayer Schering Pharma Aktiengesellschaft |
Bicyclic acyltryptophanols
|
WO2008074068A1
(en)
|
2006-12-20 |
2008-06-26 |
Prana Biotechnology Limited |
Substituted quinoline derivatives as antiamyloidogeneic agents
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
AR064491A1
(es)
|
2006-12-22 |
2009-04-08 |
Astex Therapeutics Ltd |
Derivados de imidazo[1, 2-a]pirimidina, un proceso para su preparacion, una composicion farmaceutica que los comprende y su uso en el tratamiento de enfermedades mediadas por las quinasas fgfr.
|
KR20090091306A
(ko)
|
2006-12-22 |
2009-08-27 |
노파르티스 아게 |
암, 염증 및 바이러스 감염 치료용 cdk 억제제로서의 헤테로아릴-헤테로아릴 화합물
|
CA2672213C
(en)
|
2006-12-22 |
2016-02-16 |
Astex Therapeutics Limited |
Bicyclic amine derivatives as protein tyrosine kinase inhibitors
|
FR2911140B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de 2-anilino 4-heteroaryle pyrimides, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
CN101622253B
(zh)
|
2007-01-08 |
2015-04-29 |
破立纪元有限公司 |
用于制备基于芳烃-双(二羧酰亚胺)的半导体材料的方法和用于制备它们的相关中间体
|
CN101007778A
(zh)
|
2007-01-10 |
2007-08-01 |
复旦大学 |
一种链延长型芴基双马来酰亚胺及其制备方法
|
MX2009007333A
(es)
|
2007-01-12 |
2009-08-31 |
Biocryst Pharm Inc |
Analogos de nucleosidos antivirales.
|
CN101578285A
(zh)
|
2007-01-12 |
2009-11-11 |
安斯泰来制药株式会社 |
稠合吡啶化合物
|
FR2911604B1
(fr)
|
2007-01-19 |
2009-04-17 |
Sanofi Aventis Sa |
Derives de n-(heteroaryl-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
|
JP5358962B2
(ja)
|
2007-02-06 |
2013-12-04 |
住友化学株式会社 |
組成物及び該組成物を用いてなる発光素子
|
JP2008198769A
(ja)
|
2007-02-13 |
2008-08-28 |
Nippon Steel Chem Co Ltd |
有機エレクトロルミネッセント素子
|
JP5390407B2
(ja)
|
2007-03-06 |
2014-01-15 |
ノバルティス アーゲー |
炎症またはアレルギー症状の処置に適する二環式有機化合物
|
MX2009009541A
(es)
|
2007-03-07 |
2009-09-16 |
Alantos Pharm Holding |
Inhibidores de metaloproteasa que contienen una porcion heterociclica.
|
WO2008109943A1
(en)
|
2007-03-12 |
2008-09-18 |
Cytopia Research Pty Ltd |
Phenyl amino pyrimidine compounds and uses thereof
|
US20080234262A1
(en)
|
2007-03-21 |
2008-09-25 |
Wyeth |
Pyrazolopyrimidine analogs and their use as mtor kinase and pi3 kinase inhibitors
|
EP2121648A2
(en)
|
2007-03-21 |
2009-11-25 |
EPIX Pharmaceuticals, Inc. |
S1p receptor modulating compounds and use thereof
|
US7919498B2
(en)
|
2007-03-23 |
2011-04-05 |
Amgen Inc. |
Substituted pyrazolo[3,4-d]pyrimidines as PI3K inhibitors
|
KR20080091948A
(ko)
|
2007-04-10 |
2008-10-15 |
에스케이케미칼주식회사 |
락탐형 피리딘 화합물을 포함하는 허혈성 질환의 예방 및치료용 약학조성물
|
US20100112211A1
(en)
|
2007-04-12 |
2010-05-06 |
Advanced Technology Materials, Inc. |
Zirconium, hafnium, titanium, and silicon precursors for ald/cvd
|
CA2684634A1
(en)
|
2007-04-20 |
2008-10-30 |
Schering Corporation |
Pyrimidinone derivatives and methods of use thereof
|
EP1985612A1
(en)
|
2007-04-26 |
2008-10-29 |
Bayer Schering Pharma Aktiengesellschaft |
Arymethylen substituted N-Acyl-gamma-aminoalcohols
|
WO2008141065A1
(en)
|
2007-05-10 |
2008-11-20 |
Smithkline Beecham Corporation |
Quinoxaline derivatives as p13 kinase inhibitors
|
EP1990342A1
(en)
|
2007-05-10 |
2008-11-12 |
AEterna Zentaris GmbH |
Pyridopyrazine Derivatives, Process of Manufacturing and Uses thereof
|
WO2008144253A1
(en)
|
2007-05-14 |
2008-11-27 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
GB2449293A
(en)
|
2007-05-17 |
2008-11-19 |
Evotec |
Compounds having Hsp90 inhibitory activity
|
MX2009013169A
(es)
|
2007-06-03 |
2010-04-30 |
Univ Vanderbilt |
Moduladores alostericos positivos del mglur5 benzamida y metodos de elaboracion y uso de los mismos.
|
US8163752B2
(en)
|
2007-06-07 |
2012-04-24 |
Merck, Sharp & Dohme Corp. |
Tricyclic anilide heterocyclic CGRP receptor antagonists
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
JP5129812B2
(ja)
|
2007-06-15 |
2013-01-30 |
Msd株式会社 |
ビシクロアニリン誘導体
|
ES2616355T3
(es)
|
2007-06-18 |
2017-06-12 |
Merck Sharp & Dohme B.V. |
Anticuerpos para el receptor humano de muerte programada PD-1
|
EP2018859A1
(en)
|
2007-07-26 |
2009-01-28 |
Bayer Schering Pharma Aktiengesellschaft |
Arylmethylene substituted N-acyl-beta-amino alcohols
|
EP2183027B1
(en)
|
2007-07-26 |
2011-08-31 |
Novartis AG |
Organic compounds
|
EP2020404A1
(en)
|
2007-08-01 |
2009-02-04 |
Bayer Schering Pharma Aktiengesellschaft |
Cyanomethyl substituted N-Acyl Tryptamines
|
EP2173354A4
(en)
|
2007-08-09 |
2011-10-05 |
Glaxosmithkline Llc |
CHINOXALIN DERIVATIVES AS PI3 KINASE INHIBITORS
|
WO2009019518A1
(en)
|
2007-08-09 |
2009-02-12 |
Astrazeneca Ab |
Pyrimidine compounds having a fgfr inhibitory effect
|
WO2009029625A1
(en)
|
2007-08-27 |
2009-03-05 |
Kalypsys, Inc. |
4- [heterocyclyl-methyl] -8-fluoro-quinolin-2-ones useful as nitric oxide synthase inhibitors
|
US7960400B2
(en)
|
2007-08-27 |
2011-06-14 |
Duquesne University Of The Holy Ghost |
Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof
|
PT2200436E
(pt)
|
2007-09-04 |
2015-04-29 |
Scripps Research Inst |
Pirimidinilaminas substituídas como inibidoras da proteína quinase
|
WO2009030871A1
(en)
|
2007-09-07 |
2009-03-12 |
Vernalis R & D Ltd |
Pyrrolopyrimidine derivatives having hsp90 inhibitory activity
|
TW200920357A
(en)
|
2007-09-10 |
2009-05-16 |
Curis Inc |
HSP90 inhibitors containing a zinc binding moiety
|
MX2010003606A
(es)
|
2007-10-01 |
2010-07-02 |
Isis Pharmaceuticals Inc |
Modulacion antisentido de la expresion del receptor del factor de crecimiento fibroblastico 4.
|
US8314094B2
(en)
|
2007-10-05 |
2012-11-20 |
Msd K.K |
Benzoxazinone derivative
|
WO2009047255A1
(en)
|
2007-10-09 |
2009-04-16 |
Ucb Pharma, S.A. |
Heterobicyclic compounds as histamine h4-receptor antagonists
|
WO2009049018A1
(en)
|
2007-10-10 |
2009-04-16 |
Syndax Pharmaceuticals, Inc. |
Novel compounds and methods of using them
|
CN101821243B
(zh)
|
2007-10-11 |
2013-05-08 |
中国科学院上海药物研究所 |
一类嘧啶取代苯丙酸衍生物及其作为ppar激动剂的用途
|
GB0720041D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New Compounds
|
GB0720038D0
(en)
|
2007-10-12 |
2007-11-21 |
Astex Therapeutics Ltd |
New compounds
|
WO2009047993A1
(ja)
|
2007-10-13 |
2009-04-16 |
Konica Minolta Holdings, Inc. |
有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
JP2011500702A
(ja)
|
2007-10-16 |
2011-01-06 |
ワイス・エルエルシー |
チエノピリミジンおよびピラゾロピリミジン化合物ならびにmTORキナーゼおよびPI3キナーゼ阻害剤としてのその使用
|
CA2703037A1
(en)
|
2007-10-17 |
2009-04-23 |
Novartis Ag |
Organic compounds
|
RU2007139634A
(ru)
|
2007-10-25 |
2009-04-27 |
Сергей Олегович Бачурин (RU) |
Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения
|
EP2215085B1
(en)
|
2007-10-25 |
2011-09-07 |
AstraZeneca AB |
Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders
|
WO2009056886A1
(en)
|
2007-11-01 |
2009-05-07 |
Astrazeneca Ab |
Pyrimidine derivatives and their use as modulators of fgfr activity
|
ES2893580T3
(es)
|
2007-11-28 |
2022-02-09 |
Dana Farber Cancer Inst Inc |
Inhibidores de miristato de moléculas pequeñas de Bcr-abl y métodos de uso
|
WO2009071535A1
(en)
|
2007-12-03 |
2009-06-11 |
Boehringer Ingelheim International Gmbh |
Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation
|
EA201001030A1
(ru)
|
2007-12-19 |
2011-02-28 |
Амген Инк. |
Конденсированные соединения пиридина, пиримидина и триазина в качестве ингибиторов клеточного цикла
|
AU2008345688A1
(en)
|
2007-12-21 |
2009-07-09 |
Wyeth Llc |
Imidazo [1,2-b] pyridazine compounds as modulators of liver X receptors
|
JP2011507910A
(ja)
|
2007-12-21 |
2011-03-10 |
ユニバーシティー オブ ロチェスター |
真核生物の寿命を変更するための方法
|
US8153827B2
(en)
|
2007-12-27 |
2012-04-10 |
Purdue Research Foundation |
Reagents for biomolecular labeling, detection and quantification employing Raman spectroscopy
|
FR2926297B1
(fr)
|
2008-01-10 |
2013-03-08 |
Centre Nat Rech Scient |
Molecules chimiques inhibitrices du mecanisme d'epissage pour traiter des maladies resultant d'anomalies d'epissage.
|
EA017818B1
(ru)
|
2008-01-24 |
2013-03-29 |
Андрей Александрович ИВАЩЕНКО |
ЗАМЕЩЕННЫЕ ЦИКЛОАЛКАНО[e ИЛИ d]ПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-НТРЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
|
CN101925606A
(zh)
|
2008-01-24 |
2010-12-22 |
Ucb医药有限公司 |
包含环丁氧基的化合物
|
EA017805B1
(ru)
|
2008-01-24 |
2013-03-29 |
Андрей Александрович ИВАЩЕНКО |
2-АЛКИЛАМИНО-3-АРИЛСУЛЬФОНИЛЦИКЛОАЛКАНО[e ИЛИ d]ПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-НТРЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
|
EP2244574B1
(en)
|
2008-01-25 |
2014-10-01 |
High Point Pharmaceuticals, LLC |
Tricyclic compounds as modulators of tnf- synthesis and as pde4 inhibitors
|
EP2252616B1
(en)
|
2008-01-30 |
2014-07-23 |
Genentech, Inc. |
Pyrazolopyrimidine pi3k inhibitor compounds and methods of use
|
JP2011511005A
(ja)
|
2008-02-04 |
2011-04-07 |
オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド |
2−アミノピリジン系キナーゼ阻害薬
|
WO2009103652A1
(en)
|
2008-02-22 |
2009-08-27 |
F. Hoffmann-La Roche Ag |
Modulators for amyloid beta
|
US20110190263A1
(en)
|
2008-02-22 |
2011-08-04 |
Irm Llc |
Compounds and compositions as modulators of gpr119 activity
|
JP5451646B2
(ja)
|
2008-02-27 |
2014-03-26 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
11β−ヒドロキシステロイドデヒドロゲナーゼ1型の阻害剤
|
WO2009108827A1
(en)
|
2008-02-29 |
2009-09-03 |
Wyeth |
Fused tricyclic pyrazolo[1, 5-a]pyrimidines, methods for preparation and uses thereof
|
ITTV20080039A1
(it)
|
2008-03-06 |
2009-09-07 |
Alpinestars Research Srl |
Collare di protezione in particolare per guidatori di motoveicoli
|
EP2262837A4
(en)
|
2008-03-12 |
2011-04-06 |
Merck Sharp & Dohme |
PD-1 BINDING PROTEINS
|
GB0804701D0
(en)
|
2008-03-13 |
2008-04-16 |
Amura Therapeutics Ltd |
Compounds
|
US8993580B2
(en)
|
2008-03-14 |
2015-03-31 |
Intellikine Llc |
Benzothiazole kinase inhibitors and methods of use
|
WO2009114870A2
(en)
|
2008-03-14 |
2009-09-17 |
Intellikine, Inc. |
Kinase inhibitors and methods of use
|
US20090246198A1
(en)
|
2008-03-31 |
2009-10-01 |
Takeda Pharmaceutical Company Limited |
Mapk/erk kinase inhibitors and methods of use thereof
|
WO2009122180A1
(en)
|
2008-04-02 |
2009-10-08 |
Medical Research Council |
Pyrimidine derivatives capable of inhibiting one or more kinases
|
US8436005B2
(en)
|
2008-04-03 |
2013-05-07 |
Abbott Laboratories |
Macrocyclic pyrimidine derivatives
|
US8389533B2
(en)
|
2008-04-07 |
2013-03-05 |
Amgen Inc. |
Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
|
WO2009124755A1
(en)
|
2008-04-08 |
2009-10-15 |
European Molecular Biology Laboratory (Embl) |
Compounds with novel medical uses and method of identifying such compounds
|
WO2009125808A1
(ja)
|
2008-04-11 |
2009-10-15 |
第一三共株式会社 |
アミノシクロヘキシル誘導体
|
WO2009125809A1
(ja)
|
2008-04-11 |
2009-10-15 |
第一三共株式会社 |
ピペリジン誘導体
|
EP2277881A4
(en)
|
2008-04-18 |
2011-09-07 |
Shionogi & Co |
HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON P13K
|
WO2009131687A2
(en)
|
2008-04-22 |
2009-10-29 |
Portola Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
US8309577B2
(en)
|
2008-04-23 |
2012-11-13 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
|
US7863291B2
(en)
|
2008-04-23 |
2011-01-04 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
NZ609066A
(en)
|
2008-04-29 |
2014-07-25 |
Novartis Ag |
Methods of monitoring the modulation of the kinase activity of fibroblast growth factor receptor and uses of said methods
|
JP5302389B2
(ja)
|
2008-04-29 |
2013-10-02 |
エフ.ホフマン−ラ ロシュ アーゲー |
Jnkのピリミジニルピリドンインヒビター
|
WO2009133127A1
(en)
|
2008-04-30 |
2009-11-05 |
Merck Serono S.A. |
Fused bicyclic compounds and use thereof as pi3k inhibitors
|
US9315449B2
(en)
|
2008-05-15 |
2016-04-19 |
Duke University |
Substituted pyrazoles as heat shock transcription factor activators
|
NZ588511A
(en)
|
2008-05-23 |
2012-04-27 |
Novartis Ag |
Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
|
WO2009144205A1
(en)
|
2008-05-30 |
2009-12-03 |
Basf Se |
Rylene-based semiconductor materials and methods of preparation and use thereof
|
JP2011522048A
(ja)
|
2008-06-03 |
2011-07-28 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Akt活性の阻害剤
|
EP2288671B1
(de)
|
2008-06-10 |
2012-08-15 |
Basf Se |
Neue übergangsmetall-komplexe und deren verwendung in organischen leuchtdioden - iii
|
FR2932600B1
(fr)
|
2008-06-11 |
2010-06-04 |
Areva Np |
Embout inferieur d'assemblage de combustible nucleaire
|
EP2303885B1
(en)
|
2008-06-12 |
2013-07-03 |
Merck Sharp & Dohme Corp. |
Process for producing bicycloaniline derivatives
|
GB0810902D0
(en)
|
2008-06-13 |
2008-07-23 |
Astex Therapeutics Ltd |
New compounds
|
EA201100030A1
(ru)
|
2008-06-19 |
2011-08-30 |
Астразенека Аб |
Пиразольные соединения 436
|
WO2009157423A1
(ja)
|
2008-06-24 |
2009-12-30 |
財団法人乙卯研究所 |
縮合環を有するオキサゾリジノン誘導体
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
CA2729965A1
(en)
|
2008-07-14 |
2010-01-21 |
Gilead Sciences, Inc. |
Fused heterocyclyc inhibitor compounds
|
JP5318952B2
(ja)
|
2008-07-15 |
2013-10-16 |
エフ.ホフマン−ラ ロシュ アーゲー |
新規なフェニル−イミダゾピリジン類及びピリダジン類
|
WO2010007099A1
(en)
|
2008-07-15 |
2010-01-21 |
Cellzome Limited |
2-aminoimidazo[1,2-b]pyridazine derivatives as pi3k inhibitors
|
CA2730593A1
(en)
|
2008-07-16 |
2010-01-21 |
Schering Corporation |
Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
|
UY31982A
(es)
|
2008-07-16 |
2010-02-26 |
Boehringer Ingelheim Int |
Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas
|
EP2328897A1
(en)
|
2008-07-16 |
2011-06-08 |
Schering Corporation |
Bicyclic heterocycle derivatives and their use as gpcr modulators
|
US10722562B2
(en)
|
2008-07-23 |
2020-07-28 |
Immudex Aps |
Combinatorial analysis and repair
|
EP2320907A4
(en)
|
2008-08-05 |
2012-09-05 |
Merck Sharp & Dohme |
THERAPEUTIC COMPOUNDS
|
WO2010015643A1
(en)
|
2008-08-06 |
2010-02-11 |
Novartis Ag |
New antiviral modified nucleosides
|
AU2009282480B2
(en)
|
2008-08-11 |
2015-05-07 |
Children's Medical Center Corporation |
Halofuginone analogs for inhibition of tRNA synthetases and uses thereof
|
UY32049A
(es)
|
2008-08-14 |
2010-03-26 |
Takeda Pharmaceutical |
Inhibidores de cmet
|
JP2012501962A
(ja)
|
2008-09-10 |
2012-01-26 |
田辺三菱製薬株式会社 |
芳香族含窒素六員環化合物及びその使用
|
JP6087503B2
(ja)
|
2008-09-26 |
2017-03-08 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
ヒト抗pd−1、pd−l1、及びpd−l2抗体とその用途
|
UY32158A
(es)
|
2008-10-03 |
2010-04-30 |
Astrazeneca Ab |
Derivados heterociclicos y metodos de uso de los mismos
|
WO2010045371A1
(en)
|
2008-10-15 |
2010-04-22 |
Gilead Palo Alto, Inc. |
Pyrido- and pyrimido (1, 2-a) pyrimidine compounds useful as stearoyl coa desaturase inhibitors
|
US8110578B2
(en)
|
2008-10-27 |
2012-02-07 |
Signal Pharmaceuticals, Llc |
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
|
TW201022262A
(en)
|
2008-10-29 |
2010-06-16 |
Astrazeneca Ab |
Novel compounds 515
|
US8476431B2
(en)
|
2008-11-03 |
2013-07-02 |
Itellikine LLC |
Benzoxazole kinase inhibitors and methods of use
|
WO2010052448A2
(en)
|
2008-11-05 |
2010-05-14 |
Ucb Pharma S.A. |
Fused pyrazine derivatives as kinase inhibitors
|
WO2010059552A1
(en)
|
2008-11-18 |
2010-05-27 |
Glaxosmithkline Llc |
Prolyl hydroxylase inhibitors
|
JP5743897B2
(ja)
|
2008-11-20 |
2015-07-01 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーGlaxoSmithKline LLC |
化合物
|
JP5522053B2
(ja)
|
2008-12-03 |
2014-06-18 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、有機エレクトロルミネッセンス素子材料、表示装置及び照明装置
|
KR101061599B1
(ko)
|
2008-12-05 |
2011-09-02 |
한국과학기술연구원 |
비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물
|
NZ593937A
(en)
|
2008-12-08 |
2014-05-30 |
Vm Pharma Llc |
Compositions of protein receptor tyrosine kinase inhibitors
|
US8110265B2
(en)
|
2008-12-09 |
2012-02-07 |
The Coca-Cola Company |
Pet container and compositions having enhanced mechanical properties and gas barrier properties
|
PT4209510T
(pt)
|
2008-12-09 |
2024-04-02 |
Hoffmann La Roche |
Anticorpos anti-pm-l1 e a sua utilização para a melhoria do funcionamento das células t
|
EP2376493B1
(en)
|
2008-12-12 |
2016-10-05 |
Msd K.K. |
Dihydropyrimidopyrimidine derivative
|
US8575179B2
(en)
|
2008-12-12 |
2013-11-05 |
Msd K.K. |
Dihydropyrazolopyrimidinone derivatives
|
KR101685718B1
(ko)
|
2008-12-19 |
2016-12-12 |
제넨테크, 인크. |
헤테로시클릭 화합물 및 사용 방법
|
PA8852901A1
(es)
|
2008-12-22 |
2010-07-27 |
Lilly Co Eli |
Inhibidores de proteina cinasa
|
EP2379551A1
(en)
|
2008-12-30 |
2011-10-26 |
ArQule, Inc. |
Substituted pyrazolo [3, 4-b]pyridine compounds
|
KR101714799B1
(ko)
|
2008-12-30 |
2017-03-09 |
아르퀼 인코포레이티드 |
치환된 5,6-디히드로-6-페닐벤조[f]이소퀴놀린-2-아민 화합물
|
JP5908728B2
(ja)
|
2009-01-06 |
2016-04-26 |
ダナ ファーバー キャンサー インスティテュート インコーポレイテッド |
ピリミド−ジアゼピノンキナーゼ骨格化合物及び疾患を治療する方法
|
JOP20190231A1
(ar)
|
2009-01-15 |
2017-06-16 |
Incyte Corp |
طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
|
WO2010083145A1
(en)
|
2009-01-16 |
2010-07-22 |
Merck Sharp & Dohme Corp. |
IMIDAZO[1,2-a]PYRIDINES AND IMIDAZO[1,2-b]PYRIDAZINES AS MARK INHIBITORS
|
DE102009007038A1
(de)
|
2009-02-02 |
2010-08-05 |
Merck Patent Gmbh |
Metallkomplexe
|
JP2010180147A
(ja)
|
2009-02-04 |
2010-08-19 |
Mitsubishi Gas Chemical Co Inc |
シアン酸エステル化合物、およびその硬化物
|
JP5844159B2
(ja)
|
2009-02-09 |
2016-01-13 |
ユニヴェルシテ デクス−マルセイユUniversite D’Aix−Marseille |
Pd−1抗体およびpd−l1抗体ならびにその使用
|
TW201038569A
(en)
|
2009-02-16 |
2010-11-01 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
|
TW201035102A
(en)
|
2009-03-04 |
2010-10-01 |
Gruenethal Gmbh |
Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
|
WO2010103306A1
(en)
|
2009-03-10 |
2010-09-16 |
Astrazeneca Uk Limited |
Benzimidazole derivatives and their use as antivaral agents
|
WO2010104047A1
(ja)
|
2009-03-11 |
2010-09-16 |
国立大学法人京都大学 |
多環芳香族化合物
|
CA2755251A1
(en)
|
2009-03-18 |
2010-09-23 |
Schering Corporation |
Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
|
CN102438660A
(zh)
|
2009-03-23 |
2012-05-02 |
美国西门子医疗解决公司 |
用于检测神经障碍的显像剂
|
US8288428B2
(en)
|
2009-03-27 |
2012-10-16 |
Abbott Laboratories |
Compounds as cannabinoid receptor ligands
|
WO2010117425A1
(en)
|
2009-03-31 |
2010-10-14 |
Biogen Idec Ma Inc. |
Certain substituted pyrimidines, pharmaceutical compositions thereof, and methods for their use
|
EP2417127B1
(en)
|
2009-04-06 |
2014-02-26 |
University Health Network |
Kinase inhibitors and method of treating cancer with same
|
AU2010235236B2
(en)
|
2009-04-07 |
2013-10-24 |
Emeriti Pharma Ab |
Isoxazol-3(2H)-one analogs as therapeutic agents
|
GB0906470D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
GB0906472D0
(en)
|
2009-04-15 |
2009-05-20 |
Astex Therapeutics Ltd |
New compounds
|
JP5531446B2
(ja)
|
2009-04-20 |
2014-06-25 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、有機エレクトロルミネッセンス素子材料、表示装置および照明装置
|
ES2347630B1
(es)
|
2009-04-29 |
2011-09-08 |
Universitat Ramon Llull |
Sintesis y usos de 4-cianopentanoatos y 4-cianopentenoatos sustituidos.
|
US8765754B2
(en)
|
2009-04-29 |
2014-07-01 |
Locus Pharmaceuticals, Inc. |
Pyrrolotriazine compounds
|
US20100280067A1
(en)
|
2009-04-30 |
2010-11-04 |
Pakala Kumara Savithru Sarma |
Inhibitors of acetyl-coa carboxylase
|
AR078411A1
(es)
|
2009-05-07 |
2011-11-09 |
Lilly Co Eli |
Compuesto de vinil imidazolilo y composicion farmaceutica que lo comprende
|
JP5600891B2
(ja)
|
2009-05-15 |
2014-10-08 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置および照明装置
|
JP5604808B2
(ja)
|
2009-05-20 |
2014-10-15 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
JP5629980B2
(ja)
|
2009-05-22 |
2014-11-26 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
JP5568889B2
(ja)
|
2009-05-22 |
2014-08-13 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置、照明装置及び有機エレクトロルミネッセンス素子材料
|
JP2012528083A
(ja)
|
2009-05-27 |
2012-11-12 |
コーベンハブンス ウニベルシテト |
Ncamに結合する線維芽細胞増殖因子レセプター由来ペプチド
|
JP5499519B2
(ja)
|
2009-05-27 |
2014-05-21 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
GB0910003D0
(en)
|
2009-06-11 |
2009-07-22 |
Univ Leuven Kath |
Novel compounds for the treatment of neurodegenerative diseases
|
JP5600894B2
(ja)
|
2009-06-24 |
2014-10-08 |
コニカミノルタ株式会社 |
白色有機エレクトロルミネッセンス素子、表示装置及び照明装置
|
NZ597107A
(en)
|
2009-06-25 |
2013-12-20 |
Alkermes Pharma Ireland Ltd |
Heterocyclic compounds for the treatment of neurological and psychological disorders
|
JP5732673B2
(ja)
|
2009-06-30 |
2015-06-10 |
日本ゼオン株式会社 |
新規なジアリールアミン化合物、並びに、老化防止剤、ポリマー組成物、ゴム架橋物、及び、その成形品、並びに、ジアリールアミン化合物の製造方法
|
EP2455370A1
(en)
|
2009-07-17 |
2012-05-23 |
Shionogi&Co., Ltd. |
Pharmaceutical product containing lactam or benzene sulfonamide compound
|
US8680077B2
(en)
|
2009-07-24 |
2014-03-25 |
Duke University |
Prochelators useful for inhibiting metal-associated toxicity
|
FR2948568B1
(fr)
|
2009-07-30 |
2012-08-24 |
Sanofi Aventis |
Formulation pharmaceutique
|
TWI468402B
(zh)
|
2009-07-31 |
2015-01-11 |
必治妥美雅史谷比公司 |
降低β-類澱粉生成之化合物
|
WO2011015037A1
(en)
|
2009-08-05 |
2011-02-10 |
The University Of Hongkong |
Antiviral compounds and methods of making and using there of cross reference to related applications
|
JP2012197231A
(ja)
|
2009-08-06 |
2012-10-18 |
Oncotherapy Science Ltd |
Ttk阻害作用を有するピリジンおよびピリミジン誘導体
|
ES2561659T3
(es)
|
2009-08-07 |
2016-02-29 |
Chugai Seiyaku Kabushiki Kaisha |
Derivados de aminopirazol
|
WO2011018894A1
(en)
|
2009-08-10 |
2011-02-17 |
Raqualia Pharma Inc. |
Pyrrolopyrimidine derivatives as potassium channel modulators
|
SI2467141T1
(sl)
|
2009-08-17 |
2019-03-29 |
Intellikine, Llc |
Heterociklične spojine in njihove uporabe
|
JP5577650B2
(ja)
|
2009-08-24 |
2014-08-27 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、有機エレクトロルミネッセンス素子材料、表示装置及び照明装置
|
KR101184115B1
(ko)
|
2009-08-31 |
2012-09-18 |
일동제약주식회사 |
신규 펩티드 데포르밀라제 저해제 화합물 및 그 제조방법
|
HUE024874T2
(en)
|
2009-09-03 |
2016-02-29 |
Bioenergenix |
Heterocyclic compounds for inhibiting PASK
|
CA2772790C
(en)
|
2009-09-04 |
2017-06-27 |
Benjamin Bader |
Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
|
WO2011031740A1
(en)
|
2009-09-09 |
2011-03-17 |
Achaogen, Inc. |
Antibacterial fluoroquinolone analogs
|
WO2011032050A2
(en)
|
2009-09-11 |
2011-03-17 |
Trius Therapeutics, Inc. |
Gyrase inhibitors
|
WO2011035376A1
(en)
|
2009-09-24 |
2011-03-31 |
Romar Engineering Pty Ltd |
A mould or mould core and a method of manufacturing a mould or mould core
|
WO2011041143A1
(en)
|
2009-10-01 |
2011-04-07 |
Merck Sharp & Dohme Corp. |
HETEROCYCLIC-FUSED PYRAZOLO[4,3-c]PYRIDIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
|
US8466155B2
(en)
|
2009-10-02 |
2013-06-18 |
Boehringer Ingelheim International Gmbh |
Pyrimidines
|
GB0917571D0
(en)
|
2009-10-07 |
2009-11-25 |
Karobio Ab |
Novel estrogen receptor ligands
|
EP2308866A1
(de)
|
2009-10-09 |
2011-04-13 |
Bayer CropScience AG |
Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide
|
FR2951172B1
(fr)
|
2009-10-13 |
2014-09-26 |
Pf Medicament |
Derives pyrazolopyridines en tant qu'agent anticancereux
|
US20120232062A1
(en)
|
2009-10-20 |
2012-09-13 |
Eiger Biopharmaceuticals, Inc. |
Azaindazoles to treat flaviviridae virus infection
|
KR20110043270A
(ko)
|
2009-10-21 |
2011-04-27 |
(주)씨에스엘쏠라 |
유기발광화합물 및 이를 구비한 유기발광소자
|
AP3103A
(en)
|
2009-10-22 |
2015-01-31 |
Gilead Sciences Inc |
Derivatives of purine or deazapurine useful for the treatment of (inter alia)viral infections
|
WO2011050245A1
(en)
|
2009-10-23 |
2011-04-28 |
Yangbo Feng |
Bicyclic heteroaryls as kinase inhibitors
|
MY177695A
(en)
|
2009-10-26 |
2020-09-23 |
Signal Pharm Llc |
Methods of synthesis and purification of heteroaryl compounds
|
US20120220600A1
(en)
|
2009-10-30 |
2012-08-30 |
Reiner Aichholz |
N-Oxide of 3-(2,6-dichloro-3,5-dimethoxy-phenyl) -1--1-methyl-urea
|
KR20110049217A
(ko)
|
2009-11-04 |
2011-05-12 |
다우어드밴스드디스플레이머티리얼 유한회사 |
신규한 유기 발광 화합물 및 이를 채용하고 있는 유기 전계 발광 소자
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
CA2780190C
(en)
|
2009-11-06 |
2020-05-05 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
EP2498607B1
(en)
|
2009-11-13 |
2016-02-17 |
Genosco |
Kinase inhibitors
|
RU2012125070A
(ru)
|
2009-11-18 |
2013-12-27 |
Плексксикон, Инк. |
Соединения и способы модулирования киназы и показания к их применению
|
JP2013032290A
(ja)
|
2009-11-20 |
2013-02-14 |
Dainippon Sumitomo Pharma Co Ltd |
新規縮合ピリミジン誘導体
|
EP2504010A4
(en)
|
2009-11-23 |
2013-04-17 |
Merck Sharp & Dohme |
Fused Bicyclic Pyrimidine Derivatives and Methods of Use Therefor
|
WO2011066342A2
(en)
|
2009-11-24 |
2011-06-03 |
Amplimmune, Inc. |
Simultaneous inhibition of pd-l1/pd-l2
|
EP2332939A1
(en)
|
2009-11-26 |
2011-06-15 |
Æterna Zentaris GmbH |
Novel Naphthyridine derivatives and the use thereof as kinase inhibitors
|
CN102711470A
(zh)
|
2009-12-01 |
2012-10-03 |
雅培制药有限公司 |
新的三环化合物
|
JP2011116840A
(ja)
|
2009-12-02 |
2011-06-16 |
Fujifilm Corp |
顔料微粒子分散体、これを用いた光硬化性組成物及びカラーフィルタ
|
AR079257A1
(es)
|
2009-12-07 |
2012-01-04 |
Novartis Ag |
Formas cristalinas de 3-(2,6-dicloro-3-5-dimetoxi-fenil)-1-{6-[4-(4-etil-piperazin-1-il)-fenil-amino]-pirimidin-4-il}-1-metil-urea y sales de las mismas
|
CA2782889C
(en)
|
2009-12-17 |
2014-08-05 |
Merck Canada Inc. |
Aminopyrimidines as syk inhibitors
|
US20120258940A1
(en)
|
2009-12-18 |
2012-10-11 |
Giordano Caponigro |
Method for treating haematological cancers
|
WO2011087776A1
(en)
|
2009-12-22 |
2011-07-21 |
Vertex Pharmaceuticals Incorporated |
Isoindolinone inhibitors of phosphatidylinositol 3-kinase
|
FR2954317B1
(fr)
|
2009-12-23 |
2012-01-27 |
Galderma Res & Dev |
Nouveaux derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
|
FR2954315B1
(fr)
|
2009-12-23 |
2012-02-24 |
Galderma Res & Dev |
Nouveaux derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
|
WO2011079231A1
(en)
|
2009-12-23 |
2011-06-30 |
Gatekeeper Pharmaceutical, Inc. |
Compounds that modulate egfr activity and methods for treating or preventing conditions therewith
|
US20130096115A1
(en)
|
2009-12-28 |
2013-04-18 |
Afraxis, Inc. |
Methods for treating autism
|
JP2013515785A
(ja)
|
2009-12-29 |
2013-05-09 |
ポリエラ コーポレイション |
有機半導体としてのチオン酸化芳香族ビスイミドおよびそれを組み込む装置
|
WO2011080755A1
(en)
|
2009-12-29 |
2011-07-07 |
Advinus Therapeutics Private Limited |
Fused nitrogen heterocyclic compounds, process of preparation and uses thereof
|
AU2010343102B2
(en)
|
2009-12-29 |
2016-03-24 |
Dana-Farber Cancer Institute, Inc. |
Type II Raf kinase inhibitors
|
WO2011082266A2
(en)
|
2009-12-30 |
2011-07-07 |
Arqule, Inc. |
Substituted heterocyclic compounds
|
JP2013516420A
(ja)
|
2009-12-30 |
2013-05-13 |
アークル インコーポレイテッド |
置換されたピロロ−アミノピリミジン化合物
|
WO2011082267A2
(en)
|
2009-12-30 |
2011-07-07 |
Arqule, Inc. |
Substituted triazolo-pyrazine compounds
|
CN102115026A
(zh)
|
2009-12-31 |
2011-07-06 |
清华大学 |
一维纳米结构、其制备方法及一维纳米结构作标记的方法
|
WO2011082400A2
(en)
|
2010-01-04 |
2011-07-07 |
President And Fellows Of Harvard College |
Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
|
WO2011082488A1
(en)
|
2010-01-06 |
2011-07-14 |
British Columbia Cancer Agency Branch |
Bisphenol derivative therapeutics and methods for their use
|
KR101483215B1
(ko)
|
2010-01-29 |
2015-01-16 |
한미약품 주식회사 |
단백질 키나아제 저해활성을 갖는 비시클릭 헤테로아릴 유도체
|
WO2011094890A1
(en)
|
2010-02-02 |
2011-08-11 |
Argusina Inc. |
Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
|
CA2789344A1
(en)
|
2010-02-15 |
2011-08-18 |
Jeremy Earle Wulff |
Synthesis of bicyclic compounds and method for their use as therapeutic agents
|
US9334269B2
(en)
|
2010-02-17 |
2016-05-10 |
Amgen Inc. |
Carboxamides as inhibitors of voltage-gated sodium channels
|
SA111320200B1
(ar)
|
2010-02-17 |
2014-02-16 |
ديبيوفارم اس ايه |
مركبات ثنائية الحلقة واستخداماتها كمثبطات c-src/jak مزدوجة
|
US9193728B2
(en)
|
2010-02-18 |
2015-11-24 |
Medivation Technologies, Inc. |
Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
|
CN103740434B
(zh)
|
2010-02-18 |
2016-02-03 |
Ntn株式会社 |
增稠剂、润滑脂及它们的制造方法以及润滑脂封入轴承
|
WO2011103441A1
(en)
|
2010-02-18 |
2011-08-25 |
Schering Corporation |
Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
|
UY33227A
(es)
|
2010-02-19 |
2011-09-30 |
Novartis Ag |
Compuestos de pirrolopirimidina como inhibidores de la cdk4/6
|
US9403769B2
(en)
|
2010-02-22 |
2016-08-02 |
Advanced Cancer Therapeutics, Llc |
Small molecule inhibitors of PFKFB3 and glycolytic flux and their methods of use as anti-cancer therapeutics
|
WO2011105161A1
(ja)
|
2010-02-26 |
2011-09-01 |
新日鐵化学株式会社 |
有機電界発光素子
|
US20130045203A1
(en)
|
2010-03-02 |
2013-02-21 |
Emory University |
Uses of Noscapine and Derivatives in Subjects Diagnosed with FAP
|
WO2011111880A1
(ko)
|
2010-03-08 |
2011-09-15 |
주식회사 메디젠텍 |
세포핵에서 세포질로의 gsk3의 이동을 억제하는 화합물을 함유하는 세포핵에서 세포질로의 gsk3 이동에 의해 발생되는 질환의 치료 또는 예방용 약학적 조성물
|
US20110237599A1
(en)
|
2010-03-10 |
2011-09-29 |
Kalypsys, Inc. |
Heterocyclic inhibitors of histamine receptors for the treatment of disease
|
MX350010B
(es)
|
2010-03-11 |
2017-08-23 |
Gilead Connecticut Inc |
Inhibidores syk de imidazopiridinas.
|
AU2011227643A1
(en)
|
2010-03-16 |
2012-09-20 |
Dana-Farber Cancer Institute, Inc. |
Indazole compounds and their uses
|
JP6065183B2
(ja)
|
2010-03-24 |
2017-01-25 |
アミテック セラピューティック ソリューションズ,インク. |
キナーゼ阻害に役立つ複素環式化合物
|
JP5752232B2
(ja)
|
2010-03-31 |
2015-07-22 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
プロテインキナーゼ阻害剤としての置換ピロロトリアジン化合物
|
CN102153551B
(zh)
|
2010-04-02 |
2012-04-25 |
济南海乐医药技术开发有限公司 |
基于吲唑或氮杂吲唑的双芳基脲或硫脲类结构抗肿瘤药物
|
JP5724204B2
(ja)
|
2010-04-07 |
2015-05-27 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子、表示装置、及び照明装置
|
CA2792278C
(en)
|
2010-04-13 |
2019-05-14 |
Rigel Pharmaceuticals, Inc. |
2,4-pyrimidinediamine compounds and prodrugs thereof and their uses
|
ES2707625T3
(es)
|
2010-04-16 |
2019-04-04 |
Novartis Ag |
Compuesto orgánico para su utilización en el tratamiento del cáncer de hígado
|
WO2011133750A1
(en)
|
2010-04-22 |
2011-10-27 |
Janssen Pharmaceutica Nv |
Indazole compounds useful as ketohexokinase inhibitors
|
AR081331A1
(es)
|
2010-04-23 |
2012-08-08 |
Cytokinetics Inc |
Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
|
MX2012012353A
(es)
|
2010-04-23 |
2013-02-07 |
Kineta Inc |
Compuestos anti-virales.
|
EP2563796B1
(en)
|
2010-04-30 |
2015-03-18 |
Bristol-Myers Squibb Company |
Aza-bicyclic amine n-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugs
|
GB201007286D0
(en)
|
2010-04-30 |
2010-06-16 |
Astex Therapeutics Ltd |
New compounds
|
US8759398B2
(en)
|
2010-05-03 |
2014-06-24 |
Biolink Life Sciences, Inc. |
Phosphorus binder composition for treatment of hyperphosphatemia
|
WO2011140338A1
(en)
|
2010-05-05 |
2011-11-10 |
Gatekeeper Pharmaceuticals, Inc. |
Compounds that modulate egfr activity and methods for treating or preventing conditions therewith
|
SG185487A1
(en)
|
2010-05-11 |
2012-12-28 |
Aveo Pharmaceuticals Inc |
Anti-fgfr2 antibodies
|
TWI513694B
(zh)
|
2010-05-11 |
2015-12-21 |
Amgen Inc |
抑制間變性淋巴瘤激酶的嘧啶化合物
|
CA2798831A1
(en)
|
2010-05-11 |
2011-11-17 |
Pfizer Inc. |
Morpholine compounds as mineralocorticoid receptor antagonists
|
JP2013526542A
(ja)
|
2010-05-12 |
2013-06-24 |
アッヴィ・インコーポレイテッド |
キナーゼのインダゾール阻害薬
|
ES2871021T3
(es)
|
2010-05-12 |
2021-10-28 |
Spectrum Pharmaceuticals Inc |
Hidróxido de carbonato de lantano, oxicarbonato de lantano y procedimientos de fabricación y uso
|
GB201008134D0
(en)
|
2010-05-14 |
2010-06-30 |
Medical Res Council Technology |
Compounds
|
WO2011147199A1
(en)
|
2010-05-28 |
2011-12-01 |
Versitech Limited |
Compounds and methods for treating viral infections
|
WO2011147198A1
(en)
|
2010-05-28 |
2011-12-01 |
Versitech Limited |
Compounds and methods for treatment of proliferative diseases
|
WO2011153553A2
(en)
|
2010-06-04 |
2011-12-08 |
The Regents Of The University Of California |
Methods and compositions for kinase inhibition
|
CN103038230B
(zh)
|
2010-06-04 |
2016-05-25 |
霍夫曼-拉罗奇有限公司 |
作为lrrk2调节剂的氨基嘧啶衍生物
|
WO2011155983A1
(en)
|
2010-06-07 |
2011-12-15 |
Bikam Pharmaceuticals Inc. |
Opsin-binding ligands, compositions and methods of use
|
TW201210597A
(en)
|
2010-06-09 |
2012-03-16 |
Gilead Sciences Inc |
Inhibitors of hepatitis C virus
|
US8299117B2
(en)
|
2010-06-16 |
2012-10-30 |
Metabolex Inc. |
GPR120 receptor agonists and uses thereof
|
WO2011159877A2
(en)
|
2010-06-18 |
2011-12-22 |
The Brigham And Women's Hospital, Inc. |
Bi-specific antibodies against tim-3 and pd-1 for immunotherapy in chronic immune conditions
|
EP2584903B1
(en)
|
2010-06-24 |
2018-10-24 |
Merck Sharp & Dohme Corp. |
Novel heterocyclic compounds as erk inhibitors
|
US8907053B2
(en)
|
2010-06-25 |
2014-12-09 |
Aurigene Discovery Technologies Limited |
Immunosuppression modulating compounds
|
KR101486782B1
(ko)
|
2010-06-27 |
2015-01-28 |
킹 사우드 유니버시티 |
무한 중첩된 해시 체인들에 의한 1회용 패스워드 인증
|
US8933070B2
(en)
|
2010-07-02 |
2015-01-13 |
University Health Network |
Methods of targeting PTEN mutant diseases and compositions therefor
|
FR2962437B1
(fr)
|
2010-07-06 |
2012-08-17 |
Sanofi Aventis |
Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique
|
FR2962438B1
(fr)
|
2010-07-06 |
2012-08-17 |
Sanofi Aventis |
Derives d'indolizines, procedes de preparation et application en therapeutique
|
JP2013530199A
(ja)
|
2010-07-06 |
2013-07-25 |
ノバルティス アーゲー |
キナーゼ阻害剤として有用な環状エーテル化合物
|
DE102010031127A1
(de)
|
2010-07-08 |
2012-01-12 |
Endress + Hauser Flowtec Ag |
Messaufnehmer eines thermischen Durchflussmessgeräts zur Ermittlung des Durchflusses eines Mediums durch ein Messrohr und Verfahren zu dessen Herstellung
|
AU2011276955B2
(en)
|
2010-07-09 |
2014-11-06 |
The Walter And Eliza Hall Institute Of Medical Research |
Protein kinase inhibitors and methods of treatment
|
WO2012009258A2
(en)
|
2010-07-13 |
2012-01-19 |
Edward Roberts |
Peptidomimetic galanin receptor modulators
|
EP2595996A2
(en)
|
2010-07-14 |
2013-05-29 |
Merck Sharp & Dohme Corp. |
Tricyclic compounds as allosteric modulators of metabotropic glutamate receptors
|
TW201206946A
(en)
|
2010-07-15 |
2012-02-16 |
Bristol Myers Squibb Co |
Compounds for the reduction of beta-amyloid production
|
JP5789259B2
(ja)
|
2010-07-16 |
2015-10-07 |
協和発酵キリン株式会社 |
含窒素芳香族複素環誘導体
|
WO2012008564A1
(ja)
|
2010-07-16 |
2012-01-19 |
協和発酵キリン株式会社 |
含窒素芳香族複素環誘導体
|
EP2598505B1
(en)
|
2010-07-28 |
2015-03-18 |
Bayer Intellectual Property GmbH |
Substituted imidazo[1,2-b]pyridazines
|
EP2413140A1
(en)
|
2010-07-29 |
2012-02-01 |
Sanofi |
Method for identifying a compound having an antiarrhythmic effect as well as uses relating thereto
|
TW201300501A
(zh)
|
2010-07-30 |
2013-01-01 |
羅門哈斯電子材料韓國公司 |
使用電場發光化合物作為發光材料之電場發光裝置
|
WO2012019093A1
(en)
|
2010-08-05 |
2012-02-09 |
Human Biomolecular Research Institute |
Synthetic compounds and methods to decrease nicotine self-administration
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
WO2012027236A1
(en)
|
2010-08-23 |
2012-03-01 |
Schering Corporation |
NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
|
WO2012027239A1
(en)
|
2010-08-23 |
2012-03-01 |
Schering Corporation |
NOVEL PYRAZOLO[1,5-a]PYRROLO[3,2-e]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
|
CN103189369B
(zh)
|
2010-09-01 |
2016-08-24 |
吉利德康涅狄格有限公司 |
吡啶酮/吡嗪酮、其制备方法及使用方法
|
JP5842004B2
(ja)
|
2010-09-01 |
2016-01-13 |
ジーアイリード コネチカット インコーポレーテッドGilead Connecticut,Inc. |
ピリダジノン、その製造方法及びその使用方法
|
WO2012032067A1
(en)
|
2010-09-08 |
2012-03-15 |
Glaxo Group Limited |
Polymorphs and salts of n- [5- [4- (5- { [(2r,6s) -2, 6 - dimethyl - 4 -morpholinyl] methyl} - 1, 3 - oxazol - 2 - yl) - 1h- inda zol-6-yl] -2- (methyloxy) - 3 - pyridinyl] methanesulfonamide
|
US9326987B2
(en)
|
2010-09-08 |
2016-05-03 |
Glaxo Group Limited |
Indazole derivatives for use in the treatment of influenza virus infection
|
AR082799A1
(es)
|
2010-09-08 |
2013-01-09 |
Ucb Pharma Sa |
Derivados de quinolina y quinoxalina como inhibidores de quinasa
|
TWI541243B
(zh)
|
2010-09-10 |
2016-07-11 |
拜耳知識產權公司 |
經取代咪唑并嗒
|
KR20130103503A
(ko)
|
2010-09-14 |
2013-09-23 |
호도가야 가가쿠 고교 가부시키가이샤 |
전하 제어제 및 그것을 사용한 토너
|
CN102399233B
(zh)
|
2010-09-15 |
2014-08-13 |
山东轩竹医药科技有限公司 |
PI3K和mTOR双重抑制剂类化合物
|
CN102399220A
(zh)
|
2010-09-15 |
2012-04-04 |
黄振华 |
三并环类PI3K和mTOR双重抑制剂
|
WO2012036233A1
(ja)
|
2010-09-17 |
2012-03-22 |
塩野義製薬株式会社 |
メラニン凝集ホルモン受容体アンタゴニスト活性を有する縮合へテロ環誘導体
|
GB201015949D0
(en)
|
2010-09-22 |
2010-11-03 |
Medical Res Council Technology |
Compounds
|
JO3062B1
(ar)
|
2010-10-05 |
2017-03-15 |
Lilly Co Eli |
R)-(e)-2-(4-(2-(5-(1-(3، 5-داي كلورو بيريدين-4-يل)إيثوكسي)-1h-إندازول-3-يل)?ينيل)-1h-بيرازول-1-يل)إيثانول بلوري
|
WO2012054364A2
(en)
|
2010-10-22 |
2012-04-26 |
Merck Sharp & Dohme Corp. |
Bicyclic diamines as janus kinase inhibitors
|
DK2632467T3
(en)
|
2010-10-25 |
2016-08-15 |
G1 Therapeutics Inc |
CDK inhibitors
|
JP2012092049A
(ja)
|
2010-10-27 |
2012-05-17 |
Sumitomo Chemical Co Ltd |
有害動物防除組成物及び有害動物の防除方法
|
EP2632466A4
(en)
|
2010-10-29 |
2014-03-19 |
Univ Emory |
QUINAZOLINE DERIVATIVES, COMPOSITIONS AND USES THEREOF
|
WO2012061337A1
(en)
|
2010-11-02 |
2012-05-10 |
Exelixis, Inc. |
Fgfr2 modulators
|
WO2012063207A1
(en)
|
2010-11-10 |
2012-05-18 |
Actelion Pharmaceuticals Ltd |
Lactam derivatives useful as orexin receptor antagonists
|
EP2638034A1
(en)
|
2010-11-10 |
2013-09-18 |
Grünenthal GmbH |
Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands
|
JP2012116825A
(ja)
|
2010-11-11 |
2012-06-21 |
Ehime Univ |
アセンジイミド化合物の製造方法
|
KR101171232B1
(ko)
|
2010-11-15 |
2012-08-06 |
단국대학교 산학협력단 |
스파이로 화합물 및 이를 포함하는 유기전계 발광소자
|
WO2012065297A1
(en)
|
2010-11-16 |
2012-05-24 |
Impact Therapeutics, Inc. |
3-ARYL-6-ARYL-[1,2,4]TRIAZOLO[4,3-a]PYRIDINES AS INHIBITORS OF CELL PROLIFERATION AND THE USE THEREOF
|
CA2816144A1
(en)
|
2010-11-17 |
2012-05-24 |
Amgen Inc. |
Quinoline derivatives as pik3 inhibitors
|
RU2597609C2
(ru)
|
2010-11-18 |
2016-09-10 |
Касина Лайла Иннова Фармасьютикалз Прайвит Лимитед |
Замещенные 4-(селенофен-2(или 3)-иламино)пиримидиновые соединения и способы их применения
|
GB201020179D0
(en)
|
2010-11-29 |
2011-01-12 |
Astex Therapeutics Ltd |
New compounds
|
EP2796456A1
(en)
|
2010-12-09 |
2014-10-29 |
Amgen Inc. |
Bicyclic compounds as Pim inhibitors
|
US20140031547A1
(en)
|
2010-12-14 |
2014-01-30 |
Electrophoretics Limited |
CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES
|
ES2592713T3
(es)
|
2010-12-20 |
2016-12-01 |
Merck Serono S.A. |
Derivados de indazolil-triazol como inhibidores de IRAK
|
WO2012088266A2
(en)
|
2010-12-22 |
2012-06-28 |
Incyte Corporation |
Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
|
MX339823B
(es)
|
2010-12-22 |
2016-06-13 |
Leo Laboratories Ltd |
Ingenol-3-acilatos iii e ingenol-3-carbamatos.
|
WO2012083954A1
(en)
|
2010-12-22 |
2012-06-28 |
Leo Pharma A/S |
3-acyl-ingenols ii
|
CN102603628B
(zh)
|
2010-12-22 |
2016-08-17 |
香港理工大学 |
作为抗癌试剂的喹啉衍生物
|
EP2468258A1
(en)
|
2010-12-22 |
2012-06-27 |
LEK Pharmaceuticals d.d. |
Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
|
JP2014501261A
(ja)
|
2010-12-23 |
2014-01-20 |
アムジエン・インコーポレーテツド |
複素環化合物およびそれらの使用
|
JP5691508B2
(ja)
|
2010-12-27 |
2015-04-01 |
Jnc株式会社 |
ジイミド化合物ならびにインクジェット用インクおよびその用途
|
KR101466150B1
(ko)
|
2010-12-31 |
2014-11-27 |
제일모직 주식회사 |
유기광전소자용 화합물 및 이를 포함하는 유기광전소자
|
EP2662378B1
(en)
|
2011-01-06 |
2018-10-10 |
JX Nippon Oil & Energy Corporation |
Imide compound, method for producing same, thickening agent for grease, and grease composition
|
US8362023B2
(en)
|
2011-01-19 |
2013-01-29 |
Hoffmann-La Roche Inc. |
Pyrazolo pyrimidines
|
FR2970967B1
(fr)
|
2011-01-27 |
2013-02-15 |
Pf Medicament |
Derives de type azaindazole ou diazaindazole comme medicament
|
EP2487159A1
(en)
|
2011-02-11 |
2012-08-15 |
MSD Oss B.V. |
RorgammaT inhibitors
|
US20140303144A1
(en)
|
2011-02-18 |
2014-10-09 |
Medivation Technologies, Inc. |
Compounds and methods of treating hypertension
|
JP5808826B2
(ja)
|
2011-02-23 |
2015-11-10 |
インテリカイン, エルエルシー |
複素環化合物およびその使用
|
TWI532742B
(zh)
|
2011-02-28 |
2016-05-11 |
艾伯維有限公司 |
激酶之三環抑制劑
|
CN103429759A
(zh)
|
2011-03-17 |
2013-12-04 |
诺华股份有限公司 |
Fgfr及其配体作为hr阳性对象中乳腺癌的生物标记
|
DK2688887T3
(en)
|
2011-03-23 |
2015-06-29 |
Amgen Inc |
DEHYDRATED tricyclic DUALINHIBITORER OF CDK 4/6 AND FLT3
|
ITPD20110091A1
(it)
|
2011-03-24 |
2012-09-25 |
Univ Padova |
Inibitori multitirosinchinasi utili per le patologie correlate: modelli farmacoforici, composti identificati tramite questi modelli, metodi per la loro preparazione, la loro formulazione e il loro impiego terapeutico.
|
CA2831146C
(en)
|
2011-03-25 |
2019-06-04 |
Abbvie Inc. |
Trpv1 antagonists
|
JP2014516511A
(ja)
|
2011-04-07 |
2014-07-17 |
ジェネンテック, インコーポレイテッド |
抗fgfr4抗体及び使用方法
|
FR2974088A1
(fr)
|
2011-04-12 |
2012-10-19 |
Pf Medicament |
Composes pyrazolo[3,4-b]pyridines tri- et tetracycliques comme agent anticancereux
|
MX339662B
(es)
|
2011-05-16 |
2016-06-03 |
Genentech Inc |
Antagonistas de fgfr1 y sus metodos de uso.
|
WO2012156367A1
(en)
|
2011-05-17 |
2012-11-22 |
Bayer Intellectual Property Gmbh |
Amino-substituted imidazopyridazines as mknk1 kinase inhibitors
|
WO2012158795A1
(en)
|
2011-05-17 |
2012-11-22 |
Principia Biopharma Inc. |
Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
|
AU2012255148A1
(en)
|
2011-05-19 |
2013-11-07 |
Novartis Ag |
4-amino-5-fluoro-3- [6- (4 -methylpiperazin- 1 - yl) - 1H - benzimidazol - 2 - yl] - 1H - quinolin-2-one for use in the treatment of adenoid cystic carcinoma
|
ES2625854T3
(es)
|
2011-06-01 |
2017-07-20 |
Bayer Intellectual Property Gmbh |
Aminoimidazopiridazinas sustituidas
|
UY34114A
(es)
|
2011-06-03 |
2013-01-03 |
Millennium Pharm Inc |
Combinación de inhibidores de mek e inhibidores selectivos de la quiinasa aurora a
|
KR101412437B1
(ko)
|
2011-06-13 |
2014-06-26 |
주식회사 엘지화학 |
신규한 화합물 및 이를 이용한 유기 전자 소자
|
US9284319B2
(en)
|
2011-06-22 |
2016-03-15 |
Bayer Intellectual Property Gmbh |
Heterocyclyl aminoimidazopyridazines
|
US8846656B2
(en)
|
2011-07-22 |
2014-09-30 |
Novartis Ag |
Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators
|
MX355852B
(es)
|
2011-08-12 |
2018-05-02 |
Hoffmann La Roche |
Compuestos de pirazolo [3,4-c] piridina y métodos de uso.
|
MY166970A
(en)
|
2011-08-12 |
2018-07-26 |
Nissan Chemical Ind Ltd |
Subtituted pyrrolo [2,3-h][1,6]naphthyridines and compositions thereof as jak inhibitors
|
JP2013049251A
(ja)
|
2011-08-31 |
2013-03-14 |
Fujifilm Corp |
レーザー彫刻用レリーフ印刷版原版、並びに、レリーフ印刷版及びその製版方法
|
WO2013033981A1
(zh)
|
2011-09-06 |
2013-03-14 |
江苏先声药物研究有限公司 |
一类2,7-萘啶衍生物及其制备方法和应用
|
WO2013039854A1
(en)
|
2011-09-15 |
2013-03-21 |
Merck Sharp & Dohme Corp. |
Compositions and methods for treating cancer
|
US9376435B2
(en)
|
2011-09-23 |
2016-06-28 |
Jawaharlal Nehru Centre For Advanced Scientific Research |
Chromophores for the detection of volatile organic compounds
|
CN103814029B
(zh)
|
2011-09-23 |
2016-10-12 |
拜耳知识产权有限责任公司 |
取代的咪唑并哒嗪
|
WO2013049352A2
(en)
|
2011-09-30 |
2013-04-04 |
Kineta, Inc. |
Anti-viral compounds
|
UA111382C2
(uk)
|
2011-10-10 |
2016-04-25 |
Оріон Корпорейшн |
Інгібітори протеїнкінази
|
US20140051679A1
(en)
|
2011-10-12 |
2014-02-20 |
Univeristy Health Networks |
Kinase inhibitors and method of treating cancer with same
|
KR101897044B1
(ko)
|
2011-10-20 |
2018-10-23 |
에스에프씨 주식회사 |
유기금속 화합물 및 이를 포함하는 유기전계발광소자
|
WO2013063003A1
(en)
|
2011-10-28 |
2013-05-02 |
Novartis Ag |
Method of treating gastrointestinal stromal tumors
|
BR112014009993A2
(pt)
|
2011-10-28 |
2017-04-25 |
Novartis Ag |
método para o tratamento de tumores do estroma gastrointestinal
|
WO2013088191A1
(en)
|
2011-12-12 |
2013-06-20 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3
|
BR112014014222A2
(pt)
|
2011-12-13 |
2017-06-13 |
Ecolab Usa Inc |
métodos e composições para lavagem de louças comerciais concentrados
|
FR2985258A1
(fr)
|
2011-12-28 |
2013-07-05 |
Sanofi Sa |
Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique
|
FR2985257B1
(fr)
|
2011-12-28 |
2014-02-14 |
Sanofi Sa |
Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique
|
US10026905B2
(en)
|
2012-01-18 |
2018-07-17 |
Duk San Neolux Co., Ltd. |
Compound, organic electric element using the same, and an electronic device thereof
|
WO2013109027A1
(ko)
|
2012-01-18 |
2013-07-25 |
덕산하이메탈(주) |
화합물, 이를 이용한 유기전기소자 및 그 전자 장치
|
PL2657233T3
(pl)
|
2012-01-19 |
2015-01-30 |
Taiho Pharmaceutical Co Ltd |
3,5-dipodstawiony związek alkinylobenzenowy i jego sól
|
JP6082033B2
(ja)
|
2012-02-23 |
2017-02-15 |
バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH |
置換ベンゾチエニル−ピロロトリアジンおよびその使用
|
JP2013179181A
(ja)
|
2012-02-28 |
2013-09-09 |
Sumitomo Chemical Co Ltd |
有機光電変換素子
|
GEP201706774B
(en)
|
2012-03-14 |
2017-11-27 |
Lupin Ltd |
Heterocyclyl compounds
|
AU2013241664B2
(en)
|
2012-03-30 |
2016-05-19 |
Novartis Ag |
FGFR inhibitor for use in the treatment of hypophosphatemic disorders
|
JP5120580B1
(ja)
|
2012-05-14 |
2013-01-16 |
Jsr株式会社 |
液晶配向剤
|
WO2013175468A2
(en)
|
2012-05-20 |
2013-11-28 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Prosthetic mitral valve
|
KR102406771B1
(ko)
|
2012-06-13 |
2022-06-13 |
인사이트 홀딩스 코포레이션 |
Fgfr 억제제로서 치환된 트리사이클릭 화합물
|
CA2878251A1
(en)
|
2012-07-11 |
2014-01-16 |
Novartis Ag |
Method of treating gastrointestinal stromal tumors
|
KR20200117067A
(ko)
|
2012-07-11 |
2020-10-13 |
블루프린트 메디신즈 코포레이션 |
섬유아세포 성장인자 수용체의 저해제
|
US9527875B2
(en)
|
2012-08-02 |
2016-12-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
WO2014019186A1
(en)
|
2012-08-02 |
2014-02-06 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
KR101985259B1
(ko)
|
2012-08-10 |
2019-06-03 |
제이에스알 가부시끼가이샤 |
액정 배향제 및 화합물
|
US9388185B2
(en)
|
2012-08-10 |
2016-07-12 |
Incyte Holdings Corporation |
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
|
WO2014044846A1
(en)
|
2012-09-24 |
2014-03-27 |
Evotec (Uk) Ltd. |
3-(aryl- or heteroaryl-amino)-7-(3,5-dimethoxyphenyl)isoquinoline derivatives as fgfr inhibitors useful for the treatment of proliferative disorders or dysplasia
|
WO2014048878A1
(en)
|
2012-09-26 |
2014-04-03 |
Evotec (Uk) Ltd. |
Phenyl- or pyridyl- pyrrolo[2,3b]pyrazine derivatives useful in the treatment or prevention of proliferative disorders or dysplasia
|
WO2014062454A1
(en)
|
2012-10-15 |
2014-04-24 |
Merck Sharp & Dohme Corp. |
Compositions and methods for treating cancer
|
KR102000211B1
(ko)
|
2012-10-29 |
2019-09-30 |
삼성디스플레이 주식회사 |
유기금속 화합물 및 이를 포함한 유기 발광 소자
|
RS56680B1
(sr)
|
2012-11-28 |
2018-03-30 |
Merck Sharp & Dohme |
Kompozicije i postupci za lečenje kancera
|
US20140148548A1
(en)
|
2012-11-28 |
2014-05-29 |
Central Glass Company, Limited |
Fluorine-Containing Polymerizable Monomer And Polymer Compound Using Same
|
WO2014089913A1
(zh)
|
2012-12-12 |
2014-06-19 |
山东亨利医药科技有限责任公司 |
作为酪氨酸激酶抑制剂的并环化合物
|
US9266892B2
(en)
|
2012-12-19 |
2016-02-23 |
Incyte Holdings Corporation |
Fused pyrazoles as FGFR inhibitors
|
WO2014105849A1
(en)
|
2012-12-28 |
2014-07-03 |
Xoma (Us) Llc |
Antibodies specific for fgfr4 and methods of use
|
TWI629266B
(zh)
|
2012-12-28 |
2018-07-11 |
藍印藥品公司 |
纖維母細胞生長因子受體之抑制劑
|
KR102030587B1
(ko)
|
2013-01-09 |
2019-10-10 |
에스에프씨주식회사 |
두 개의 나프틸기를 포함하는 비대칭 안트라센 유도체 및 이를 포함하는 유기 발광 소자
|
WO2014113191A1
(en)
|
2013-01-15 |
2014-07-24 |
Xiaohu Zhang |
Hedgehog pathway signaling inhibitors and therapeutic applications thereof
|
CN103694236B
(zh)
|
2013-01-15 |
2017-05-31 |
苏州开拓药业股份有限公司 |
一种嘧啶骨架具有刺猬通路拮抗剂活性的抗肿瘤化合物
|
KR101456626B1
(ko)
|
2013-02-01 |
2014-11-03 |
대영이앤비 주식회사 |
냉장고 부압 방지 장치
|
JP6311093B2
(ja)
|
2013-03-07 |
2018-04-18 |
国立大学法人九州大学 |
超分子複合体、発光体、および有機化合物検出用のセンサー素子
|
WO2014138485A1
(en)
|
2013-03-08 |
2014-09-12 |
Irm Llc |
Ex vivo production of platelets from hematopoietic stem cells and the product thereof
|
US9498532B2
(en)
|
2013-03-13 |
2016-11-22 |
Novartis Ag |
Antibody drug conjugates
|
EP2968285A4
(en)
|
2013-03-13 |
2016-12-21 |
Flatley Discovery Lab |
COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS
|
JP2016510788A
(ja)
|
2013-03-14 |
2016-04-11 |
アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー |
ホスホジエステラーゼ10a型の新規な阻害剤化合物
|
JP6576325B2
(ja)
|
2013-03-15 |
2019-09-18 |
セルジーン シーエーアール エルエルシー |
ヘテロアリール化合物およびそれらの使用
|
WO2014160521A1
(en)
|
2013-03-15 |
2014-10-02 |
Blueprint Medicines Corporation |
Piperazine derivatives and their use as kit modulators
|
NZ711376A
(en)
|
2013-03-15 |
2020-01-31 |
Sanofi Sa |
Heteroaryl compounds and uses thereof
|
TWI647220B
(zh)
|
2013-03-15 |
2019-01-11 |
美商西建卡爾有限責任公司 |
雜芳基化合物及其用途
|
TWI628176B
(zh)
|
2013-04-04 |
2018-07-01 |
奧利安公司 |
蛋白質激酶抑制劑
|
KR101573611B1
(ko)
|
2013-04-17 |
2015-12-01 |
주식회사 엘지화학 |
플러렌 유도체, 이를 이용한 유기 태양 전지 및 이의 제조 방법
|
EP3318564B1
(en)
|
2013-04-19 |
2021-07-28 |
Incyte Holdings Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
MX2015014608A
(es)
|
2013-04-19 |
2016-03-03 |
Covagen Ag |
Novedosas moleculas de union biespecifica con actividad antitumoral.
|
GB201307577D0
(en)
|
2013-04-26 |
2013-06-12 |
Astex Therapeutics Ltd |
New compounds
|
US9630963B2
(en)
|
2013-05-09 |
2017-04-25 |
Principia Biopharma, Inc. |
Quinolone derivatives as fibroblast growth factor inhibitors
|
CA2915321A1
(en)
|
2013-06-14 |
2014-12-18 |
Sanofi |
Pyrazolopyridine derivatives for use in the treatment of bladder cancer
|
JP6380862B2
(ja)
|
2013-06-28 |
2018-08-29 |
ベイジーン リミテッド |
複数種類のキナーゼの阻害剤としての縮合三環式アミド系化合物
|
CN109369671B
(zh)
|
2013-06-28 |
2021-07-27 |
百济神州有限公司 |
作为Raf激酶和/或Raf激酶二聚体抑制剂的稠合三环脲类化合物
|
EP3016949B1
(en)
|
2013-07-02 |
2020-05-13 |
Syngenta Participations AG |
Pesticidally active bi- or tricyclic heterocycles with sulfur containing substituents
|
JP6018547B2
(ja)
|
2013-07-09 |
2016-11-02 |
大成ロテック株式会社 |
舗装機械
|
US9783504B2
(en)
|
2013-07-09 |
2017-10-10 |
Dana-Farber Cancer Institute, Inc. |
Kinase inhibitors for the treatment of disease
|
CN117486865A
(zh)
|
2013-07-11 |
2024-02-02 |
艾森医药公司 |
嘧啶衍生物作为激酶抑制剂
|
TW201605452A
(zh)
|
2013-08-28 |
2016-02-16 |
安斯泰來製藥股份有限公司 |
以嘧啶化合物作爲有效成分之醫藥組成物
|
AU2014337291B9
(en)
|
2013-10-18 |
2020-05-07 |
Eisai R&D Management Co., Ltd. |
Pyrimidine FGFR4 inhibitors
|
JP6458023B2
(ja)
|
2013-10-25 |
2019-01-23 |
ブループリント メディシンズ コーポレイション |
繊維芽細胞成長因子受容体の阻害剤
|
PL3060563T3
(pl)
|
2013-10-25 |
2018-10-31 |
Novartis Ag |
Pierścienio-skondensowane bicykliczne pochodne pirydylowe jako inhibitory fgfr4
|
FR3012330B1
(fr)
|
2013-10-29 |
2015-10-23 |
Oreal |
Composition biphase comprenant un ester d'acide gras et de sucre ou un alkylpolyglucoside liquide, de hlb < 8, et un alcane ramifie en c8-c18
|
WO2015066452A2
(en)
|
2013-11-01 |
2015-05-07 |
Foundation Medicine, Inc. |
Methods of treating pediatric cancers
|
WO2015108992A1
(en)
|
2014-01-15 |
2015-07-23 |
Blueprint Medicines Corporation |
Heterobicyclic compounds and their use as fgfr4 receptor inhibitors
|
ES2904544T3
(es)
|
2014-08-19 |
2022-04-05 |
Shanghai Haihe Pharmaceutical Co Ltd |
Compuestos de indazol como inhibidores de la cinasa FGFR, preparación y uso de los mismos
|
CN104262330B
(zh)
|
2014-08-27 |
2016-09-14 |
广东东阳光药业有限公司 |
一种脲取代联苯类化合物及其组合物及用途
|
TN2017000092A1
(en)
|
2014-09-19 |
2018-07-04 |
Bayer Pharma AG |
Benzyl substituted indazoles as bub1 inhibitors.
|
US10851105B2
(en)
|
2014-10-22 |
2020-12-01 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
WO2016064960A1
(en)
|
2014-10-22 |
2016-04-28 |
Incyte Corporation |
Bicyclic heterocycles as fgfr4 inhibitors
|
WO2016134294A1
(en)
|
2015-02-20 |
2016-08-25 |
Incyte Corporation |
Bicyclic heterocycles as fgfr4 inhibitors
|
ES2751669T3
(es)
|
2015-02-20 |
2020-04-01 |
Incyte Corp |
Heterociclos bicíclicos como inhibidores FGFR
|
WO2016134292A1
(en)
|
2015-02-20 |
2016-08-25 |
Oregon Health & Science University |
Derivatives of sobetirome
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
WO2016192680A1
(en)
|
2015-06-03 |
2016-12-08 |
Triastek, Inc. |
Dosage forms and use thereof
|
CN108026315B
(zh)
|
2015-07-15 |
2021-02-09 |
卡博特公司 |
制造用硅石增强的弹性体复合物的方法以及包含其的制品
|
WO2017011820A2
(en)
|
2015-07-15 |
2017-01-19 |
Protagonist Therapeutics, Inc. |
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
|
MY189596A
(en)
|
2015-07-15 |
2022-02-18 |
Immatics Biotechnologies Gmbh |
A novel peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
|
PE20180356A1
(es)
|
2015-07-15 |
2018-02-21 |
Hoffmann La Roche |
Derivados de etinilo como moduladores del receptor metabotropico del glutamato
|
TWI833183B
(zh)
|
2015-07-30 |
2024-02-21 |
美商宏觀基因股份有限公司 |
Pd-1結合分子和其使用方法
|
US10392383B2
(en)
|
2015-08-03 |
2019-08-27 |
Samumed, Llc |
3-(1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017024015A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10231956B2
(en)
|
2015-08-03 |
2019-03-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10195185B2
(en)
|
2015-08-03 |
2019-02-05 |
Samumed, Llc |
3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10188634B2
(en)
|
2015-08-03 |
2019-01-29 |
Samumed, Llc |
3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017024025A1
(en)
|
2015-08-03 |
2017-02-09 |
Sunil Kumar Kc |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017024004A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
CA2996018C
(en)
|
2015-08-20 |
2024-02-06 |
Changzhou Jiekai Pharmatech Co., Ltd. |
Pyrazolo fused heterocyclic compounds as erk inhibitors
|
WO2017058915A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
ES2928164T3
(es)
|
2015-10-19 |
2022-11-15 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
AU2016341445B2
(en)
|
2015-10-23 |
2020-08-27 |
Array Biopharma, Inc. |
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases
|
LT3377488T
(lt)
|
2015-11-19 |
2023-01-10 |
Incyte Corporation |
Heterocikliniai junginiai, kaip imunomoduliatoriai
|
US20170174671A1
(en)
|
2015-12-17 |
2017-06-22 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
BR112018012756A2
(pt)
|
2015-12-22 |
2018-12-04 |
Incyte Corp |
compostos heterocíclicos como imunomoduladores
|
MA44860A
(fr)
|
2016-05-06 |
2019-03-13 |
Incyte Holdings Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
WO2017205464A1
(en)
|
2016-05-26 |
2017-11-30 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
SI3472167T1
(sl)
|
2016-06-20 |
2022-11-30 |
Incyte Corporation |
Heterociklične spojine kot imunomodulatorji
|
TW201803871A
(zh)
|
2016-06-24 |
2018-02-01 |
英塞特公司 |
作為PI3K-γ抑制劑之雜環化合物
|
US20180016260A1
(en)
|
2016-07-14 |
2018-01-18 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
US20180057486A1
(en)
|
2016-08-29 |
2018-03-01 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
US10647693B2
(en)
|
2016-08-30 |
2020-05-12 |
North & South Brother Pharmacy Investment Company Limited |
Inhibitors of influenza virus replication, application methods and uses thereof
|
US20180072718A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridine compounds and uses thereof
|
MX2019003938A
(es)
|
2016-10-05 |
2019-06-10 |
Zeno Royalties & Milestones Llc |
Compuestos espirociclicos.
|
KR101755556B1
(ko)
|
2016-11-18 |
2017-07-07 |
주식회사 케마스 |
육산화사비소의 결정다형을 포함하는 뇌암 예방 또는 치료용 약학 조성물 및 이의 제조방법
|
KR101834366B1
(ko)
|
2016-11-21 |
2018-03-05 |
주식회사 케마스 |
육산화사비소의 결정다형을 포함하는 유방암 예방 또는 치료용 약학 조성물 및 이의 제조방법
|
KR101844049B1
(ko)
|
2016-12-05 |
2018-03-30 |
주식회사 케마스 |
육산화사비소의 결정다형을 포함하는 간암 예방 또는 치료용 약학 조성물
|
KR101844050B1
(ko)
|
2016-12-09 |
2018-05-14 |
주식회사 케마스 |
육산화사비소의 결정다형을 포함하는 암 예방 또는 치료용 약학 조성물
|
CN110267953B
(zh)
|
2016-12-22 |
2022-12-20 |
因赛特公司 |
四氢咪唑并[4,5-c]吡啶衍生物作为pd-l1内在化诱导剂
|
AU2017382870B2
(en)
|
2016-12-22 |
2022-03-24 |
Incyte Corporation |
Benzooxazole derivatives as immunomodulators
|
EP3558973B1
(en)
|
2016-12-22 |
2021-09-15 |
Incyte Corporation |
Pyridine derivatives as immunomodulators
|
MA47099A
(fr)
|
2016-12-22 |
2021-05-12 |
Incyte Corp |
Composés hétéroaromatiques bicycliques utilisés en tant qu'immunomodulateurs
|
US20180177784A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
US20180179201A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
WO2018234354A1
(en)
|
2017-06-20 |
2018-12-27 |
Grünenthal GmbH |
NOVEL SUBSTITUTED 3-INDOLE AND 3-INDAZOLE COMPOUNDS AS PHOSPHODIESTERASE INHIBITORS
|
US11242334B2
(en)
|
2017-08-22 |
2022-02-08 |
Js Innopharm (Shanghai) Ltd. |
Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof
|
AU2018352695A1
(en)
|
2017-10-19 |
2020-05-28 |
Effector Therapeutics, Inc. |
Benzimidazole-indole inhibitors of Mnk1 and Mnk2
|
DK3717471T3
(da)
|
2017-12-02 |
2022-01-31 |
Galapagos Nv |
Nye forbindelser og lægemiddelsammensætninger heraf til behandling af sygdomme
|
HRP20230090T1
(hr)
|
2018-03-30 |
2023-03-17 |
Incyte Corporation |
Heterociklički spojevi kao imunomodulatori
|
MA52493A
(fr)
|
2018-05-04 |
2021-03-10 |
Incyte Corp |
Sels d'un inhibiteur de fgfr
|
DK3788047T3
(da)
|
2018-05-04 |
2024-09-16 |
Incyte Corp |
Faste former af en FGFR-inhibitor og fremgangsmåder til fremstilling deraf
|
CN112752756B
(zh)
|
2018-05-11 |
2024-06-25 |
因赛特公司 |
作为PD-L1免疫调节剂的四氢-咪唑并[4,5-c]吡啶衍生物
|
EP3836923A4
(en)
|
2018-08-14 |
2022-05-18 |
Osteoqc Inc. |
PYRROLO-DIPYRIDINE COMPOUNDS
|
EP3846904B1
(en)
|
2018-09-07 |
2023-05-31 |
Merck Patent GmbH |
5-morpholin-4-yl-pyrazolo[4,3-b]pyridine derivatives
|
US20210355547A1
(en)
|
2018-10-20 |
2021-11-18 |
The Johns Hopkins University |
Non-invasive urinary biomarkers for the detection of urothelial carcinoma of the bladder
|
WO2020131627A1
(en)
|
2018-12-19 |
2020-06-25 |
Array Biopharma Inc. |
Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of fgfr tyrosine kinases
|
US20220041579A1
(en)
|
2018-12-19 |
2022-02-10 |
Array Biopharma Inc. |
Substituted quinoxaline compounds as inhibitors of fgfr tyrosine kinases
|
WO2020185532A1
(en)
|
2019-03-08 |
2020-09-17 |
Incyte Corporation |
Methods of treating cancer with an fgfr inhibitor
|
WO2021007269A1
(en)
|
2019-07-09 |
2021-01-14 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
WO2021067374A1
(en)
|
2019-10-01 |
2021-04-08 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
WO2021076602A1
(en)
|
2019-10-14 |
2021-04-22 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
WO2021076728A1
(en)
|
2019-10-16 |
2021-04-22 |
Incyte Corporation |
Bicyclic heterocycles as fgfr inhibitors
|
CN115151539A
(zh)
|
2019-12-04 |
2022-10-04 |
因赛特公司 |
Fgfr抑制剂的衍生物
|
CA3163875A1
(en)
|
2019-12-04 |
2021-06-10 |
Incyte Corporation |
Tricyclic heterocycles as fgfr inhibitors
|
US12012409B2
(en)
|
2020-01-15 |
2024-06-18 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
JP2024513575A
(ja)
|
2021-04-12 |
2024-03-26 |
インサイト・コーポレイション |
Fgfr阻害剤及びネクチン-4標的化剤を含む併用療法
|